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Targeted drug delivery to the brain is difficult to achieve using conventional
techniques, largely due to the blood-brain barrier’s (BBB) impediment to drug diffusion
into the brain parenchyma. In response, development of convection-enhanced delivery
(CED) offers the ability to circumvent the BBB and target specific areas of the brain.
Predictability of infusate movement in pathological brain states during CED will
maximize the effectiveness of this treatment, and therefore modeling of infusate
movement must be characterized. Previous work from our lab effectively modeled CED
in rats using the middle carotid artery occlusion model of cytotoxic edema. However,
previous models examined for vasogenic edema study did not show pure vasogenic
edema. The purpose of this study was to develop a model of pure vasogenic edema in the
rat brain. In this study, we show that stereotactic 9 µL infusion of 1.0 mM DCA over 45
ix

x

minutes into the rat corpus callosum reproducibly creates pure vasogenic edema, as
observed in the peritumoral white matter surrounding gliomas.

Chapter 1
Introduction

The Blood-Brain Barrier
Neuroscience literature describes the blood-brain barrier (BBB) as both a
structural and functional impediment to the movement of molecules from blood vessels
into the brain parenchyma. Paul Ehrlich showed the first evidence of the BBB when he
demonstrated that intravenously-administered dyes stained many tissues except brain in
the late 1800s. Further experiments by his student, Edwin Goldman, showed that the
dyes themselves had the ability to stain brain parenchyma when exposed to the brain
through non-intravenous methods (Wells and Bonetta 2005).

Modern experimental

techniques have since elucidated the complex cellular and molecular structures that
comprise this barrier between blood and the brain (Huber et al. 2001), which is
particularly limiting for high molecular weight (MW) and polar molecules (Bobo et al.
1994).
Histologically, the BBB consists of vascular endothelial cells connected by tight
junctions and adherens junctions.

Pericytes overlay the endothelial cells and are

considered part of the BBB because they participate in its function and share a common
basement membrane with the endothelial cells (Ueno 2007). Figure 1-1 provides an
1
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Figure 1-1. Illustration of the BBB and perivascular astrocytic foot processes. Figure
modified from Uneo (2007).
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illustration of the BBB. Astrocytic foot processes ensheath this structure and participate
in its maintenance (Neuwelt 2004). In fact, the CNS microenvironment is necessary for
formation and maintenance of tight junctions by endothelial cells (Stewart and Wiley
1981; Argaw et al. 2006). Still, endothelial cells contribute to the metabolic requirement
necessary for BBB function, and mitochondria comprise a large intracellularpresence in
the endothelial cell ultrastructure (Ueno 2007).
Tight junctions between the endothelial cells limit paracellular permeability of
molecules with a MW larger than 200-400 Da between the blood vessel lumen and brain
parenchyma, while other mechanisms of transport across the endothelium play minor
roles (Neuwelt 2004). The network of tight junctions between endothelial cells is also
referred to as the zonula occludens (Wang and Margolis 2007). The structure of tight
junctions consists of integral, transmembrane proteins that attach cytoplasmic accessory
proteins on the intracellular face. Claudins, occludins and junction adhesion molecules
all comprise the integral membrane component of tight junctions (Huber et al. 2001).
Adherens junctions also consist of transmembrane proteins, namely members of the
cadherin family. Cytoplasmic accessory proteins attach tight junctions and adherens
junctions to the actin cytoskeleton of the endothelial cell. ZO-1, ZO-2, ZO-3, cingulin,
and additional proteins attach tight junctions, while p120 and catenins attach adherens
junctions (Doolittle et al. 2005; Ueno 2007).
As suggested above, the responsibility of BBB maintenance lies with astrocytes,
endothelial cells and pericytes (Neuwelt 2004; Ueno 2007). Astrocytic interaction with
the endothelium is necessary for proper development and maintenance of the BBB
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(Laterra et al. 1990), and astrocytes also maintain a suitable CNS microenvironment for
the cells and structures involved.

In pathological brain states such as neuro-

inflammation, factors secreted by microglia and macrophages (such as Il-1β and
histamine) lead to reactive astrogliosis and BBB disruption by interactions with the
astrocytes and endothelium (Argaw et al. 2006).
Under normal conditions, protein kinase C (PKC) in the endothelial cell asserts
several important functions in tight junction regulation (Huber et al. 2001). One such
function is the maintenance of appropriate intracellular calcium levels, which is necessary
for proper cadherin function and ZO-1 migration within the cytoplasm. In addition,
phosphorylation activity by PKC permits ZO-1 migration and proper sorting of tight
junction proteins.

PKC also regulates intracellular adhesion molecule 1 (ICAM-1)

transcription induced by tumor necrosis factor α (TNFα).
Although proper BBB function is necessary for a normal brain environment
(Neuwelt 2004), it provides a major obstacle in conventional drug delivery to CNS
pathologies such as tumors and neurodegenerative disorders (Groothuis 2000). As stated
above, high MW and polar molecules do not readily pass the BBB, and therapeutic agents
often have these characteristics (Bobo et al. 1994).

However, novel treatments to

circumvent the BBB are being developed such as implantable polymers and convectionenhanced delivery (CED) of drugs (Groothuis 2000; Haroun and Brem 2000). The
overlying goal of our lab is to optimize CED in pathological brain states, which will
permit appropriate doses of therapeutic agents to reach the desired area.

6

Convection-Enhanced Delivery
Delivery of medication into the brain has proven a major challenge to clinicians,
and scientists continue to search for optimal ways of appropriately delivering drugs to
specific targets. Largely due to the BBB, medication from the bloodstream diffuses
poorly into the brain parenchyma, especially with increasing molecular weight (Broaddus
et al. 2001). In 1977, Vick et al. (Vick et al. 1977; Groothuis et al. 2000) stated that the
BBB did not provide a major obstacle to chemotherapeutic delivery and predicted that
research on factors other than the BBB, such as dosage and route of delivery, would
improve drug delivery. Although supported by some, the large majority of literature
supports the idea that the BBB provides a major obstacle to drug delivery (Groothuis
2000).
Common methods of drug delivery rely on simple diffusion of the drug to the
target tissue. The ability of a substance to diffuse relies on the properties of both the drug
and the target tissue environment. Several properties in particular hold great importance
for brain such as MW, polarity, and the BBB (Bobo et al. 1994). For example, diffusivity
into normal brain rapidly decreases with increasing MW (Groothuis et al. 1999).
Similarly, diffusion of high MW compounds into brain tumor tissue occurs slowly.
Novel therapeutics (e.g. polypeptides, proteins or nucleic acids) tend to have high MW,
and therefore simple diffusion to pathologic brain states from the vasculature is
inadequate. Given orally or intravascularly, the diffusion of compounds into the normal
brain is much lower than into other target tissues, and the body acts as a large sink for
most of the drug. This sink effect also reduces the ability of the physician to deliver high
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doses of a drug to a localized target. Even for compounds with the capability to cross the
BBB, any associated toxicity may affect other regions of the body and not localize to the
brain (Haroun and Brem 2000).
Infusion of drugs into the brain’s ventricular system does allow the surgeon to
bypass the blood-cerebrospinal fluid (CSF) barrier, but has also proven unsuccessful due
to the requirement that the compound diffuse from CSF into the brain parenchyma. Even
with compounds that would be expected to diffuse readily, diffusion alone cannot
adequately deliver medication to the brain (Zovickian et al. 1987). The amount of drug
found in brain following intraventricular delivery is high at the ventricular border and
sharply decreases with increasing distance from the ventricular wall (Blasberg et al.
1975; Patlak and Fenstermacher 1975; Groothuis and Levy 1997). Intraventricular drug
delivery is thus suitable for pathologies in the subarachnoid space such as carcinomatous
meningitis (Brown et al. 1996) but not for intraparenchymal delivery (Groothuis 2000).
Localization of drugs to the target area allows for higher dosing and the potential
to leave healthy tissue unharmed. One approach uses degradable wafers containing the
drug for direct intraparenchymal implantation. MGI Pharma markets 3.85% BCNUimpregnated polymer wafers that are implanted on the margins of the resection cavity
after removing primary brain tumors. This therapeutic strategy has undergone phase III
clinical trials and has been demonstrated to improve mean survival time to 31 weeks
compared to 23 weeks for placebo wafers (Bota et al. 2007). Although this improvement
is modest, it still shows the value and promise of local drug delivery as opposed to
systemic delivery.
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Utilizing the immune system provides another avenue for localization of drugs to
the pathological area. Even when given systemically, immunotherapeutics are intended
to specifically target a tumor due to their ability to enhance the natural immune response
a body creates in response to the tumor. Cancer cells often show resistance to the
immune response, also called immune evasion (Melero et al. 2007) and in vivo use of
certain cytokines such as IL-2, 4, and 12 is currently under study to enhance the efficacy
of the natural immune response. Preliminary results, though, have shown significant
systemic toxicity for IL-2 in early clinical trials (Haroun and Brem 2000).
Although the above techniques address the problem of localization, diffusion is
still the final common pathway for drugs to distribute throughout the target tissue and no
technique has yielded impressive results. As mentioned above, diffusion is only effective
within very short (millimeter) distances, the concentration of the drug declines
dramatically with increasing distance from its source, and tissue clearance can rapidly
deplete the drug before it can diffuse over a long distance. In addition, the large MWs
characteristic of many therapeutics exacerbates the shortcomings of diffusion-based
techniques.

In response to the issue of diffusion, researchers at the NIH began to

optimize convection-enhanced delivery (CED), which creates a positive pressure gradient
driving the bulk flow of infusate fluid (Bobo et al. 1994).
Bobo et al. (1994) infused increasing volumes of

111

In –labeled transferrin (111In-

Tf) and [14C]sucrose into the corona radiata of cats over time as representative high and
low MW compounds. In their paper the authors describe the convection pressure in
relation to the flow rate for infusion and the positive linear relationship between volume
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of infusate (Vi) and volume of distribution (Vd) of the infusate attributable to convection.
Optimization of CED has since been a major focus to ensure predictable and effective
drug delivery with minimal side effects for the patient. Infusion covering an area of even
a few centimeters takes numerous hours to complete, which places tremendous strains on
the patient (Morrison et al. 1994). Therefore, development of proper technology and
determination of adequate dosing, volume, and flow rate have undergone much
investigation (Groothuis 2000).
The initial low flow rate is critical to prevent fluid backflow up the needle tract,
and small incremental increases in the flow rate can be made during longer infusions
(Bobo et al. 1994; Chen 1999). Flow rates and cannula diameter have been the focus of
technical optimization due to the greater risk of infection and patient discomfort of long
infusions (Morrison et al. 1994; Chen et al. 1999; Krauze et al. 2005a; Linninger et al.
2008). Generally infusion occurs from narrow-diameter cannulas (26-32 gage) (Krauze
et al. 2005a) at approximately 0.5 µL/min or lower, and then flow rate is increased
incrementally by 0.5 or 1 µL/min to minimize reflux of infusate along the cannula track
(Bobo et al. 1994). Morrison first reported high-flow rate infusion without reflux at 3
µL/min over a 12-hour period using large-MW compounds that produced an infusion
radius of 1.5 cm (Morrison et al. 1994). Recently, however, Krauze et al. (2005b)
developed a “reflux-free” cannula that allows 10-fold higher flow rates without tissue
damage or backflow as tested first in agarose gel, and then confirmed in rat and primates.
Predictability of Vd relies on the surgeon knowing exactly how much infusate will reach
the tissue under a properly-maintained convection pressure.
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Another method of increasing the Vd is to increase the infusate concentration, as
demonstrated by Kroll et al. (1996). When flow rate and Vi are kept constant but the
infusate concentration is increased fivefold, Vd will experience a remarkable 79%
increase. The authors of the study suggested that higher doses of the drug would thus
enhance therapeutic benefit over a larger target area, which would ideally reduce the time
required for infusion (Kroll et al. 1996). Although short infusion times are ideal, other
studies have investigated the effect of a long duration of infusion on the brain
parenchyma. Laske et al. (1997) performed 87-hour infusions into the primate brainstem
at a moderate infusion rate of 1.7 µL/min and showed consistent and reproducible V d.
Despite this long infusion, only a mild astrocytic response was observed and blood
perfusion to the infused area decreased by less than 5%. These findings indicate that the
principal concern of long infusions is the duration of anesthesia administration as
opposed to the procedure itself.
Predictability of infusate movement in the tissue is integral to proper clinical use
of CED. Fluid movement in gray matter versus white matter differs due to properties of
the extracellular matrix and the cellular structures (Morrison et al. 1994, Haar 2005), and
fluid movement through pathological brain tissue also differs from normal brain tissue
(Haar 2005). Gray matter parenchyma is considered homogenous and primarily consists
of cell bodies, and has a tortuous ECM.

White matter, however, is considered

heterogeneous and consists primarily of tracts of axonal processes surrounded by myelin
sheaths, and has a less tortuous ECM than that of gray matter (Morrison et al. 1994, Haar
2005). Fluid movement through the ECS of gray matter is generally isotropic, whereas
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fluid movement through white matter ECS occurs preferentially in parallel with the axon
tracts and is thus anisotropic (Haar 2005). The ratio of Vi:Vd following CED should
presumably follow different patterns depending on the location and type of pathology
present (Raghavan et al. 2006).
A number of studies have set out to model infusate movement with respect to
predicted distributions and actual distributions observed. Published work from our lab
has utilized gel phantoms (Chen et al. 2002) in addition to animal experimentation
(Broaddus et al. 1998; Prabhu et al. 1998) to quantifiably model infusate distribution
using CED.

Several quantifiable parameters affecting distribution have been cited,

including tissue hydraulic conductivity, resting pore fraction, irreversible drug loss from
tissue, tissue dilation, etc. (Raghavan et al. 2006).

Although formulas have been

developed based on these variables to predict infusate movement for a given region of
tissue, results have shown that our understanding is incomplete (Prabhu et al. 1998;
Raghavan et al. 2006; Linninger et al. 2008). Further understanding both of tissue
properties and fluid movement through the tissue is thus necessary before effective CED
can be achieved.
Previous work in our lab investigated infusate distribution in pathological brain
states, namely pure cytotoxic edema and pure vasogenic edema (Haar 2005). Using the
middle carotid artery occlusion (MCAO) model of cytotoxic edema, Haar showed that
gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA), a mock therapeutic infusate
distributes to a larger tissue volume in cytotoxic edema relative to normal brain in rats.
Further, clearance of the infusate from brain with cytotoxic edema took longer than
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clearance from normal brain. Unfortunately, inconclusive results were observed when
Haar infused Gd-DTPA into a model of vasogenic edema, which were in part attributed
to intrinsic problems with the model that did not produce pure vasogenic edema. Later,
Shukla (2006) optimized a different model but was also unable to create edema that was
purely vasogenic. In response to these findings by Haar (2005) and Shukla (2006),
purpose of this study was to optimize a different model of pure vasogenic edema.
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Cerebral Edema
A feature common to many brain pathologies is edema. Such conditions include
traumatic brain injury (TBI), intracerebral hemorrhage, brain tumors and stroke
(Hutchinson et al. 2007). Raslan and Bhardwaj (2007) define edema as an appreciable
increase in brain water content. Several subtypes have been described, although the three
major forms are cytotoxic, vasogenic, and interstitial. Cytotoxic edema results from
water increase that is intracellular, whereas fluid confined to the extracellular space
(ECS), typically as a result of serum water and proteins extravasated across a breached
BBB, defines vasogenic edema (Klatzo 1967). Interstitial edema is also referred to as
hydrocephalic edema, and it results from CSF buildup that leads to hydrocephalus
(Raslan and Bhardwaj 2007).
A thorough understanding of edema has permitted the development of clinical
treatments (Heiss et al. 1996), although further improvements are necessary (Raslan and
Bhardwaj 2007). Our lab is particularly interested in drug delivery to edematous brain
using CED. The goal of this study in particular is to find a reproducible model of pure
vasogenic edema that would be appropriate for our CED investigation. Several models of
vasogenic edema exist, but unfortunately the edema consists of a heterogeneous mixture
of vasogenic and cytotoxic types, which is not appropriate for our purposes.
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Figure 1-2. Illustrations of normal brain (A), vasogenic edema with characteristics ECS
expansion (B), and cytotoxic edema with characteristics ECS contraction and
intracellular swelling (C). Figure taken from Shukla (2006).
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Vasogenic Edema
The late Igor Klatzo, a leader in the field of edema research, asserted that in
normal brain, serum proteins cannot readily cross the BBB like water and electrolytes.
Compromise of the BBB, however, will permit serum proteins and fluid to move from the
vasculature to the brain parenchyma, hence the term vasogenic edema. The two major
extravasated proteins found in the ECS in this circumstance are immunoglobin G (IgG)
and albumin (Klatzo 1987). Proteins will remain in the ECS following resealing of the
BBB or upon diffusion to an area with the BBB intact, maintaining an edematous state
until they have been cleared (Kuroiwa et al. 1985; Klatzo 1987).
Three major mechanisms of extracellular protein clearance include uptake by
astrocytes, bulk flow to ventricles, and digestion or transport within luminal vesicles of
endothelial cells (Klatzo et al. 1980; Klatzo 1987), although diffusion has been shown to
play a minor role (Marmarou et al. 1990). It was previously thought that the astrocytic
pathway was the predominant mechanism of edema fluid clearance (Klatzo et al. 1980;
Klatzo 1987). However, later studies by other authors showed evidence of albumin
clearance along perivascular spaces into the ventricles and dorsally to the subarachnoid
space, and the authors posited that these routes provided the major clearance pathway for
edema fluid (Ohata et al. 1990; Ohata and Marmarou 1992; Abbott 2004; Marmarou
2007). Astrocytic assistance in edema resolution does occur (Klatzo 1987), particularly
via the uptake of albumin through the transforming growth factor (TGF)-β receptor
(Ivens et al. 2007); water presumably flows into the astrocytes concurrently with the
albumin (Klatzo 1987).

Additionally, ECS expansion is thought to put a strain on
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metabolic needs of cells other than astrocytes (Klatzo 1987), and mechanical stress to
their membranes, particularly in neurons at the vulnerable nodes of Ranvier, has been
suggested to induce cellular swelling (Ohata et al. 1990). Therefore, intracellular fluid
uptake can latently be observed during vasogenic edema and the resultant pathology will
be a heterogeneous mixture of vasogenic and cytotoxic forms (Klatzo 1994).
Cytotoxic Edema
Although cellular uptake of fluid in brain occurs predominantly in astrocytes,
cytotoxic edema affects neurons and other cells as well. Klatzo attributed the initial
stages of cytotoxic edema to tissue depravation of glucose and oxygen, causing cells to
lose control of the Na+/K+ ATPase pump. Due to this event, the cell cannot properly
regulate osmolarity and will begin retaining water (Klatzo 1987). Typically ischemia, as
seen in stroke, leads to cytotoxic edema, and the time course of cellular swelling (R
Katzman et al. 1977) followed later by BBB disruption is well-documented (Gotoh et al.
1985). Experimentally, middle cerebral artery occlusion is a reproducible model of
cytotoxic edema. Studies of this model have revealed that the brain begins retaining Na+
and water concurrent with K+ loss within 12 hours, and BBB permeability to albumin is
observed between 12 to 24 hours (Gotoh et al. 1985; Hatashita and Hoff 1990). Similar
to vasogenic edema, cytotoxic edema temporally evolves into a heterogeneous mixture of
these two types (Katzman et al. 1977; Gotoh et al. 1985; Hatashita and Hoff 1990; Klatzo
1994).
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Aquaporins
Aquaporins (AQPs) are a recently-discovered family of transmembrane protein
channels integral to water transport (Papadopoulos and Verkman 2007). A diversity of
species including bacteria and mammals express aquaporins, and they exist in many
tissues in the human body. The brain relies on AQPs for CSF production and for
astrocytic regulation of water and BBB maintenance. These channels have the capacity
for bidirectional water transport, a feature that forms the cornerstone of an ongoing
debate among edema researchers (Griesdale et al. 2004). Specifically, the evaluation of
AQP-4 in edematous brain, expressed on the astrocytic endfeet enveloping capillaries
(Nielsen et al. 1997), as protective or harmful to the parenchyma has yet to be fully
understood (Marmarou 2007; Papadopoulos and Verkman 2007). Stroke models with
overexpression (Yang et al. 2008) and knockout (Manley et al. 2000) of AQP-4 found
that AQP-4 overexpression enhances the edema, as evidenced by respective greater and
less edema observed in these parameters when compared to normal brain. This channel
has thus been implicated as a contributor to the pathogenesis of cytotoxic edema. Indeed,
inability of a cell to control its water is characteristic of cytotoxic edema, and AQP-4
would not be expected to provide reprieve for the cell as a passive water channel
(Marmarou 2007; Papadopoulos and Verkman 2007).
In contrast to its harmful role in cytotoxic edema, Papadopoulos et al. (2004)
found a reduction in edema and ICP in wild-type mice compared to AQP-4 -/- mice in
three models of vasogenic edema (intraparenchymal fluid injection, freeze lesion and
brain tumor), suggesting a protective role in this pathology. Freeze lesion and brain
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tumor models induce edema through BBB breakdown and serum protein extravasation,
whereas intraparenchymal fluid injection does not create edema through a compromised
BBB. This aspect highlights the role of AQP-4 as an endogenous tool that the brain uses
to protect itself in this particular pathology. In fact, VEGF has recently been shown to
upregulate AQP-4 mRNA and protein expression in rats following infusion into the
substantia nigra, which coincided with return of BBB function (Rite et al. 2008).
Although the VEGF-induced BBB breakdown initially harms the dopaminergic neurons
of this region (Rite et al. 2007), the authors posited that the subsequent AQP-4
upregulation allowed the region to remove excess water as quickly as possible and
thereby reduce the total injury volume (Rite et al. 2008). In humans, Saadoun et al.
(2002) reported a large upregulation of AQP-4 in reactive astrocytes of the parenchyma
surrounding all but one of the examined high-grade astrocytomas, whereas expression in
similar tissue surrounding low-grade astrocytomas equaled that of normal brain. This
finding supports the finding by Rite et al. that the brain responds in a self-protective
fashion to vasogenic edema through upregulation of AQP-4 (Rite et al. 2008).
Traumatic Brain Injury
TBI has been attributed to long-term disabilities in an astounding 5.3 million
Americans. The pathophysiology itself is complex, and its specifics can vary depending
on a number of factors, including the age, gender and severity of the traumatic event.
Nevertheless, TBI pathologies have several common characteristics including
excitotoxicity, metabolic deregulation, inflammation and edema (Keck et al. 2007).
Edema subsequent to TBI has been shown to be heterogeneous, but with a predominance
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of cytotoxic edema (Marmarou et al. 2006). Barzó et al. (1997) describes the edema
subsequent to TBI as biphasic, with vasogenic edema appearing in the acute stages
followed by cellular swelling. Following treatment of Marmarou’s impact acceleration
model in rats, edema was observed on MRI T1 water maps for 2 weeks. ADC values
transiently increased up to 60 minutes post-injury before declining to below-baseline
values, where they remained for over 2 weeks. Ultrastructural evaluation of this model in
the acute phase shows perivascular edema as well as astrocytic swelling (Foda and
Marmarou 1994; Vaz et al. 1998) that persists for 24 hours but is not visible thereafter
(Foda and Marmarou 1994).
A notable feature of the impact acceleration model is the mild increase in blood
pressure from 102 to 123 mmHg that decreases to hypotensive levels from 15 seconds to
30 minutes post-injury (Marmarou et al. 1994). Similarly, experimental fluid percussion
injury (FPI) creates an even greater rise in blood pressure that persists over a longer time
course (van den Brink et al. 1990; Yuan et al. 1991). Oddly enough, edema following
FPI persists for only 5 days post-injury (McIntosh et al. 1990). Van den Brink et al.
(1994) posited that the “key event” in edema formation from both FPI and impact
acceleration, though, was damage to the vasculature including BBB breakdown and loss
of blood pressure autoregulation.
Intracerebral Hemorrhage
Edema secondary to a cerebral hemorrhage can compose up to 75% of the
perihematomal volume. In the first 48 hours following the event, breakdown of the BBB
due to the action of thrombin allows vasogenic edema to accompany the existing lesion.

21

Adding insult to injury, the breakdown products of the red blood cells, particularly those
from hemoglobin, initiate an inflammatory immune response, keeping the region
edematous (Thiex and Tsirka 2007). It is widely believed that the edema exacerbates the
hemorrhagic injury, largely due to the action of thrombin and its downstream effectors in
the event cascade (Xi et al. 1999). Yang et al. (1994) described the progression of
cerebral hemorrhagic edema following injection of autologous blood into the rat caudate
nucleus as similar to the edema following ischemia.

The water content increased

progressively for 24 hours and remained constant for 5 days, after which edema began to
decrease. Also, the full spread of edema extended beyond the area of BBB disruption
observed locally around the clot.
The perihematomal area which experiences inflammation and edema has been the
target of studies to reduce the total lesion size. Elevated cytokines, particularly IL-6,
IL10 and IL-1β are observed (Thiex and Tsirka 2007), with some thought to be protective
while others are thought to be harmful. IL-6 is thought to have a protective role through
inhibition of MMP-9 (Cucullo et al. 2003; Vajtr et al. 2008), whereas Masada et al.
(2003) managed to attenuate edema following both autologous blood and thrombin
infusion with administration of IL-1 receptor antagonists (Thiex and Tsirka 2007).
Collectively, these findings demonstrate the complexity of hemorrhagic edema,
particularly with respect to the immune response and subsequent inflammation present in
this brain state.
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Peritumoral Edema
In addition to treatment of brain tumors, treatment of peritumoral edema has also
received a great deal of attention. Clinical management of this complex edema correlates
to better patient outcome following neurosurgical procedures and limits the volume of
brain affected indirectly by the tumor (Stummer 2007). Over time, peritumoral edema
causes peritumoral cyst formation, as well (Baggenstos et al. 2007). Alterations of the
vasculature and ultimately breakdown of the BBB permit the edema formation, and
inhibition of tumor-specific cytokines known to cause BBB breakdown, especially VEGF
(Carlson et al. 2007; Stummer 2007) and COX-2, has been shown to attenuate
peritumoral edema (Stummer 2007). The vasculature displays ultrastructural evidence of
BBB breakdown such as abnormal tight junctions, irregular basal lamina and fenestrated
capillaries (Stewart et al. 1985; Shibata 1989; Stummer 2007).
Experimental tumor models have provided a wealth of knowledge about the
edema present in this pathology. Within the tight junctions of edematous peritumoral
vasculature, altered protein expression of occludins (Papadopoulos et al. 2001) and
claudins (Liebner et al. 2000) has been observed, creating the paracellular portal through
which the serum ultrafiltrate extravasates (Papadopoulos et al. 2001). Edema generated
locally around the tumor then spreads radially away from the tumor, mostly parallel to
white matter tracks (Stummer 2007), as the intratumoral pressure is greater than that of
surrounding parenchyma (Li et al. 2006).

This edema is said to be predominantly

vasogenic because extravasated fluid resides mostly in the ECS (Papadopoulos et al.
2004).
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Models of Vasogenic Edema
The literature documents many experimental models of vasogenic edema. Many
involve a breach of the BBB to permit extravasation of serum fluid and proteins, a
characteristic that is observed in clinical practice as seen on MRI with gadolinium (Gd)enhanced T1 imaging. However, direct intraparenchymal infusion places a proteinaceous
fluid infusate directly into the ECS without BBB disruption (Haar 2005). Clinical edema
is complex and variable depending on the broader pathology, and development of various
edema models permits accurate study of a diverse range of injuries (Haar 2005).
Cold Lesion
Cold lesion is a highly reproducible model of vasogenic brain edema that has
been used since the 1950s (Bartkowski et al. 1985). The injury is produced by placement
of a cold metal probe onto the exposed scalp or underlying dura mater following
craniotomy. The severity of the lesion can vary depending on the temperature of the
probe, typically between -68oC to -80oC (Houkin et al. 1996; Stoffel et al. 2004), and the
duration of probe placement, which is usually 30 seconds (Papadopoulos et al. 2004;
Stoffel et al. 2004; Nag 1996). Following placement of the probe over the exposed skull,
a necrotic lesion immediately forms in the brain region directly underneath the probe.
The total lesion expands to a maximal volume at 24 hours post-operatively that is
maintained for several days (Stoffel et al. 2004). Apoptosis is observed for 24 hours
within the primarily necrotic core of the lesion, but at 72 hours only the margin of the
necrotic lesion contains apoptotic cells (Murakami et al. 1997).
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Lesion expansion is attributed to the development of vasogenic edema
surrounding the necrotic lesion as a result of BBB breakdown and serum extravasation.
BBB breakdown occurs immediately post-injury and persists up to 24 hours as seen both
from Evan’s Blue extravasation and Gd-enhanced T1 MR imaging (Houkin et al. 1996;
Murakami et al. 1997). Specifically, altered tight junction protein expression occurs in a
temporal fashion. Interestingly, caveolin-1 expression is increased up to 4 days postinjury before returning to control level, whereas occludin and claudin-5 show varying
levels of decrease before returning to normal (Nag et al. 2007). Decreased expression of
junction adhesion molecule (JAM)-A has also been observed. Further, an important
regulator of tight junction molecules similarly displays an altered expression profile
following cold injury. Both endothelial (e) and inducible (i) nitrous oxide synthase
(iNOS) (Nag et al. 2001) are overexpressed in astrocytes (Gotoh et al. 1998) for 4 days
after cold injury.
Intraparenchymal Albumin Infusion
Unlike many other models of vasogenic edema, direct intraparenchymal infusion
creates vasogenic edema while the BBB remains intact. Albumin, the major component
of serum ultrafiltrate in vasogenic edema, dissolved in mock cerebrospinal fluid (CSF) is
distributed directly to the extracellular space where it remains for 8 days as visualized by
MRI (Fatouros et al. 1990) and TEM (Ohata et al. 1990). Without albumin, the same
volume of mock CSF remains only for 72 hours (Groeger and Marmarou 1989).
Especially in comparison with other models, the edema produced is thought to be purely
vasogenic; cellular pathology is not observed and edema clearance occurs primarily along
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perivascular routes instead of through cellular uptake (Ohata et al. 1990). This model has
been used to examine pathways of protein and fluid clearance in vasogenic edema
(Naruse et al. 1990; Ohata et al. 1990; Ohata and Marmarou 1992), and more recently by
our lab to model infusate movement in an edematous state (Haar 2005). Unfortunately,
intrinsic characteristics of the model did not permit adequate results for that particular
study.
Mannitol
Over the last half century, a number of studies have documented reversible BBB
opening using hyperosmolar agents. Due to the BBB, many therapeutic agents cannot
reach the brain parenchyma and conventional methods of delivery have thus proven
inadequate.

Because of their ability to reversibly open the BBB, manipulation of

hyperosmolar agents to improve drug delivery has received a great deal of attention
(Kroll and Neuwelt 1998; Rapoport 2000). In addition, clinicians have used this same
manipulation in attempts to lower acute intracranial pressure. This technique remains
controversial and no conclusion of its clinical effectiveness has been solidified
(Kaufmann and Cardoso 1992; Kroll and Neuwelt 1998; Rapoport 2000).
Clinically, a single bolus of 1.4 mM (25%) mannitol is administered to the
internal carotid artery to induce BBB disruption that reduces edema and elevated ICP.
Each month this can be done once a day for 2 days but for a maximum of 12 months.
This BBB opening is mild, short-lived, and thought to attenuate an existing pathology
where vasogenic edema is present. From this method, the BBB remains open widely for
40 minutes and returns to normal between 6-8 hours post-infusion (Siegal et al. 2000).
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Experimentally, a single dose of 1.4 mM mannitol via the intracarotid infusion to healthy
rat brain will also open the BBB. This opening occurs maximally for 5 minutes before
returning towards normal (Cosolo et al. 1989). Studies from Shukla (2006) in our lab
have shown that 3 intracarotid infusions of 1.4 mM mannitol given 30 minutes apart can
produce extensive BBB disruption and create large edema in the rat brain.

EB

extravasation is observed within 2 hours following the last infusion, and extensive edema
is observed by hyperintense T2 signal on MRI throughout the ipsilateral cortex, caudate,
and corpus callosum. Significant mass effect is also observed. The extensive edema
does lead to cellular pathology within 24 hours, and many rats do not survive the
procedure even in the acute stages (Shukla 2006). This model does not meet the criteria
of pure vasogenic edema, and consequently our lab sought other models.
Vascular Endothelial Growth Factor (VEGF)
Vascular endothelial growth factor (VEGF) is a powerful cytokine that induces
neovascularization. The protein was originally discovered for its ability to increase
vascular permeability around tumors, and was therefore named vascular permeability
factor (VPF) (Murohara et al. 1998). VEGF upregulation occurs in most brain tumors,
particularly in aggressive ones (Jain et al. 2007). Blockage of VEGF by steroids (Heiss
et al. 1996), antibodies and exogenously-applied VEGF receptors (Gorski et al. 1999) can
effectively attenuate peritumoral edema and reduce mass effect of brain tumors (Jain et
al. 2007). Vascular permeability is observed within 1 minute following injection as the
result of a leaky BBB, and neovascularization occurs much later (Dvorak 2002). In vitro
studies have demonstrated a biphasic nature of BBB opening due to VEGF exposure to
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cultured vascular endothelial cells. An initial “rapid and transient phase” occurs over the
first 2 hours, followed by a “delayed and sustained phase” from 6-24 hours (Behzadian et
al. 2003).
The edema response to VEGF is largely due to the inflammatory response that it
creates. Croll et al demonstrated vascular leak and leukocyte after one day of continuous
intracortical VEGF infusion via mini-osmotic pumps, and levels of both increased
throughout the 7-day period.

The inflammatory response included increased IgG

extravasation, leukocyte extravasation, and ICAM-1 (an important adhesion molecule in
diapedesis). All of these inflammatory elements contributed to the leaky vasculature that
preceded neovascularization by several days (Croll et al. 2004). Intraventricular delivery
of VEGF has also been shown to induce edema and neovascularization in the
subventricular zone. Similar to Croll, Harrigan et al. (2003) used mini-osmotic pumps
for continuous intraventricular VEGF infusion, and showed increase brain water content
as well as neovascularization.
Bile Acids
Bile acids are cholesterol derivatives synthesized in the gut that circulate through
the enterohepatic circulation. Although their primary function is the emulsification of
lipids, they assert essential roles in the biochemical regulation of glucose and lipid
metabolism. Bile acids exert these actions through a number of common intracellular
signaling pathways, including protein kinase C (PKC) and FAS-receptor. In addition,
bile acids bind the nuclear farnesoid X receptor (FXR) through which they can affect
other intracellular pathways (Scotti et al. 2007). Depending on concentration and type,
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bile acids can paradoxically promote cell (Dent et al. 2005) survival or induce apoptosis
(Redlak et al. 2003). Conjugated bile acids (bile acids covalently attached to taurine or
glycine) have been shown to upregulate the cell survival proteins Akt and extracellular
regulated kinase (ERK)1/2 in human hepatocytes; this interaction is observed in the
normal gut and thought to be essential for proper gastrointestinal function (Dent et al.
2005).

Alternatively, ovarian cancer cells in vitro demonstrate a dose-dependent

apoptotic response to deoxycholic acid (DCA) (Redlak et al. 2003).
DCA is a secondary bile acid, meaning that it is synthesized by flora in the gut
(Scotti et al. 2007), and several studies have utilized DCA for its ability to produce brain
edema in experimental animals (Seiffert et al. 2004). Its relative hydrophobicity permits
DCA to integrate into lipid membranes, from which point it is thought to alter tight
junctions between opposing ends of vascular endothelial cells and thus permit serum
protein and fluid extravasation (Greenwood et al. 1991; Todd et al. 1997; Seiffert et al.
2004).

As mentioned above, bile acids (including DCA) are known to alter PKC

signaling in many cell types of the visceral organs and also alter intracellular calcium
fluxes in these cells (Scotti et al. 2007).

Tight junction maintenance depends on

modulation by PKC and proper calcium regulation (Huber et al. 2001), and DCA may
alter the tight junction integrity through those mechanisms
Greenwood et al. (1991) showed a dose-response of DCA on RBC lysis and on
BBB function. RBCs exposed to increasing concentrations of DCA demonstrated that
DCA exerted “lytic action” at 1.5 mM and above. In a separate set of experiments,
increasing concentrations of DCA were perfused intracarotidly with [14C]mannitol in
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exsanguinated animals. The group showed that a minimum concentration of 1.0 mM
DCA was necessary to induce BBB disruption as evidence by mannitol extravasation
(mannitol concentration used was not high enough to contribute to BBB disfunction).
However, concentrations of 2.0 mM DCA and higher caused pathologic morphology in
the vascular endothelial cells. The authors concluded 1.0 mM DCA was the optimal
concentration for BBB disruption while maintaining the integrity of vascular endothelial
cells.
Perfusion of DCA over the surface of the cortex has also been shown to induce
BBB disruption resulting in vasogenic edema (Seiffert et al. 2004; Tomkins et al. 2007).
A concentration of 1.0 mM DCA caused immediate albumin extravasation as evaluated
by EB staining (Seiffert et al. 2004). Cortical perfusion with 2.0 mM DCA caused
albumin extravasation, as well as increased T1 and T2 signals on MRI (Tomkins et al.
2007). The authors also demonstrated that albumin uptake by astrocytes did not occur
until 6-8 hours post-perfusion, suggesting that extravasated albumin remained in the
extracellular space along with the extravasated fluid for that duration.
The aforementioned VEGF and DCA models have not demonstrated that the
edema produced is purely one type or a heterogeneous mixture of vasogenic and
cytotoxic types. We designed experiments using these two substances with the intent of
creating pure vasogenic edema, and defined criteria to evaluate whether or not this state
was created. Establishment of pure vasogenic edema will permit the study of CED in this
specific brain state by our lab, and the model can certainly be applied to other studies of
vasogenic edema as well.

Chapter 2
Hypothesis and Specific Aims

Rationale: Thorough examination of many models of edema has not shown that an
existing model can reproducibly create pure vasogenic edema. Several new approaches
were attempted based on existing models, such that issues with old ones were ideally
eradicated. We attempted to create pure vasogenic edema in the rat brain by modification
of existing models of VEGF infusion and DCA infusion. Further, we compared these
models to a real case of peritumoral edema.

Hypothesis I: Direct intraparenchymal infusion of VEGF will demonstrate a dosedependence and time-dependence on BBB disruption and edema formation in the rat
striatum.
Specific Aims:
1. Establish a dose at which BBB disruption will occur.
a) Demonstrate the time course over which BBB disruption occurs.
2. Establish whether significant edema is produced by BBB disruption.
a) Characterize the edema as purely vasogenic, purely cytotoxic, or
heterogeneous
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Hypothesis II: Direct intraparenchymal infusion of DCA will demonstrate a dosedependence and time-dependence on BBB disruption and edema formation in the rat
corpus callosum.
Specific Aims:
1. Establish a dose at which BBB disruption will occur.
a) Demonstrate the time course over which BBB disruption occurs.
2. Establish whether significant edema is produced by BBB disruption.
a) Characterize the edema as purely vasogenic, purely cytotoxic, or
heterogeneous.
Hypothesis III: Peritumoral edema in the rat corpus callosum is purely vasogenic.
Specific Aims:
1. Establish whether significant peritumoral edema exists in the corpus
callosum of rats bearing T9 gliomas
a) Characterize the edema as purely vasogenic, purely cytotoxic, or
heterogeneous.

Chapter 3
Methods

All animal experiments were approved by the Committee for the Care and Use of
Laboratory Animals at Virginia Commonwealth University. Male Sprague-Dawley rats
(Harlan, Indianapolis, Indiana) with an average weight range of 300 – 350 grams were
used for all infusions of saline, VEGF, and DCA. Methods used were similar or equalent
to those used by Haar (2005), Shukla (2006), and Parry (2007). In addition to these
groups, brain tissue from female Fisher 344 rats (Harlan, Indianapolis, Indiana) weighing
approximately 140 grams and bearing T9 glioma tumors was donated by Dr. Zhi-jian
Chen from his experiments; methods for surgery, tumor implantation, sacrifice, and tissue
processing in these animals are summarized under the heading “Donation of TumorBearing Rats” at the end of this chapter.

Stereotactic Infusion
Male Sprague-Dawley rats were anesthetized by intraperitoneal administration of
90 mg/kg ketamine : 10 mg/kg xylazine (10 : 1 mixture of ketamine [100 mg/mL] :
32
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xylazine [50 mg/mL]). Lubricating veterinary ointment was applied to the eyes and the
animal was placed on a heating pad in a stereotactic frame. A 10 mm midline incision
was made at the scalp, centered approximately at bregma. An infusion burr hole was
stereotactically created 3mm lateral, 1mm posterior to bregma using a roto-tool and fine
drill bit for all infusions. A 28-gague needle attached to a 100 µL Hamilton syringe
driven by a syringe pump (Bioanalytical Systems, West Lafayette, Indiana) was lowered
6mm below the surface of the brain for striatum infusions and 2.5 mm below the surface
of the brain for corpus callosum infusions and remained in the brain parenchyma for 5
minutes before infusion. Five minutes after infusion, the infusion needle was slowly
raised 1 mm every minute until out of the brain. The incision was then closed with
absorbable chromic gut, averaging 6 interrupted sutures along the length of the incision
and the rat was placed under a heat source and monitored until alert and mobile. Animals
sacrificed less than 24 hours post-operatively were not given analgesic. For animals
sacrificed 24 hours or longer post-operatively, buprenorphine (0.03 mL, 0.3 mg/mL) was
administered subcutaneously every 12 hours up to 72 hours.
20 µL of 0.1 µg/mL, 1 µg/mL, and 5 µg/mL VEGF in PBS was infused into the
right striatum at a flow rate of 0.25 µL/min for 80 minutes and given intravenous Evan’s
Blue (EB) dye before being sacrificed at 1 hour post-infusion

(n=2 for each

concentration). Brains were then harvested and then grossly section in the coronal plane
at the needle track with a razor blade to look for EB staining. Brain tissue at needle tract
was then stained with hematoxylin and eosin by the Department of Anatomic Pathology
at Virginia Commonwealth University, Richmond, Virginia. A parallel set of animals
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(n=2) received 20 µL of 0.1 µg/mL VEGF in PBS, and was given EB before sacrifice at
20 hours post-infusion. These brains received gross sectioning as previously described,
but were not stained with hematoxylin and eosin.
6 and 12 µL of DCA was infused at 2.0 mM in 0.9% saline into the right striatum
at a flow rate of 0.2 µL/min for 30 and 60 minutes, respectively. Animals (n=2 per
volume group) were given EB and sacrificed at 1 hour, after which brains received gross
sectioning, as described above for stereotactic VEGF infusion. For a second group, 6, 9,
12, and 18 µL of DCA was infused at 2.0 mM in 0.9% saline into the right corpus
callosum at a flow rate of 0.2 µL/min for 30, 45, 60, and 90 minutes, respectively.
Animals (n=2 per volume group) were given EB and sacrificed at 1 hour, after which
brains received gross sectioning as described above for stereotactic VEGF infusion. A
third set of animals (n=2 per time group) received 18 µL of 2.0 mM DCA and were given
EB and sacrificed 5 hours, 1 day, 1 week, and 2 weeks post-infusion. Brains were
examined by gross sectioning. A fourth set of animals (n=2) received 9 µL of 2.0 mM
DCA were sacrificed 1 hour post-infusion. Brains were sectioned by vibratome and
parallel samples were processed for GFAP immunohistochemistry and electron
microscopy preparation, as described below. 2 more animals received 9 µL of 2.0 mM
DCA and were saved for MRI at 1 day post-infusion, after which animals were sacrificed.
Brains were sectioned by vibratome and parallel samples were processed for GFAP
immunohistochemistry and electron microscopy preparation.
6 and 12 µL of 1.0 mM DCA in saline was infused into the right striatum at a
flow rate of 0.2 µL/min for 30 and 60 minutes, respectively. Animals (n=2 per volume
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group) receiving 6 and 12 µL were given EB and sacrificed at 1 hour, after which brains
were examined by gross sectioning. In a separate experiment, 6, 9, and 12 µL of 1.0 mM
DCA in saline was infused into the right corpus callosum at a flow rate of 0.2 µL/min for
30, 45, and 60 minutes, respectively. Animals (n=2 per volume group) receiving 6 and
12 µL of 1.0 mM DCA were given EB and sacrificed at 1 hour, after which brains were
examined by gross sectioning. Animals (n=2 per time group) receiving 9 µL of 1.0 mM
DCA were given EB and sacrificed at 1 hour and 1 day, after which brains were
sectioned

by

vibratome

and

parallel

samples

were

processed

for

GFAP

immunohistochemistry and electron microscopy preparation.
9 µL of 0.5 mM DCA was infused at a flow rate of 0.2 µL/min for 45 minutes.
One group of animals (n=3) receiving 0.5 mM DCA was saved for MRI 1 hour and then
sacrificed. A second group of animals (n=3) receiving 0.5 mM DCA was saved for MRI
at 1 day and then sacrificed. A third group of animals (n=2) receiving 0.5 mM DCA was
given EB and sacrificed at 1 hour. A fourth group of animals (n=2) receiving 0.5 mM
DCA was given EB and sacrificed at 1 day. For the third and fourth groups, brains were
sectioned by vibratome and parallel samples were processed for GFAP immunohistochemistry and electron microscopy preparation.
18 µL of 0.9% saline (vehicle) was infused at a flow rate of 0.2 µL/min for 90
minutes into the right corpus callosum. Animals (n=2) were sacrificed at 1 hour postinfusion, and brains were sectioned by vibratome and parallel samples were processed for
GFAP immunohisto-chemistry and electron microscopy preparation.
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Osmotic Pump Implantation
Alzet mini-osmotic pumps (DURECT Corporation, Cupertino, California) were
filled with 200 µL of 1 µg/mL VEGF in PBS, and Alzet micro-osmotic pumps
(DURECT Corporation, Cupertino, California) were filled with 90 µL of 1 µg/mL VEGF
in PBS. Pumps were attached to Alzet brain infusion kit II (DURECT Corporation,
Cupertino, California) and primed by incubation in sterile 0.9% saline at 37 oC for 24
hours before implantation.
Each rat was anesthetized by intraperitoneal administration of 90 mg/kg ketamine
: 10 mg/kg xylazine (10 : 1 mixture of ketamine [100 mg/mL] : xylazine [50 mg/mL]).
Lubricating veterinary ointment was applied to the eyes and the animal was placed on a
heating pad in a stereotactic frame. A 10 mm midline incision was made at the scalp,
centered approximately at bregma. An infusion burr hole was stereotactically marked
3mm lateral, 1mm posterior to bregma.

From the posterior of the incision site,

subcutaneous pocket was made and the pump was placed inside. Then, the first burr hole
was created 3 mm posterior to the infusion mark using a roto-tool and fine drill bit. The
burr hole was manually threaded with a metal screw, the rise of which was calculated and
compared to the thickness of the skull to prevent injury to the brain. The cannula of the
brain infusion kit was placed onto the infusion burr hole and temporarily fixed with
superglue. After 5 minutes, the stereotactic arm was raised, and dental cement (Hygenic,
Akron, OH) was applied around the base of the guide cannula and nylon screw.
Allowing enough time to set, the incision was then closed with absorbable chromic gut,
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averaging 6 interrupted sutures along the length of the incision. Buprenorphine (0.03
mL, 0.3 mg/mL) was administered subcutaneously every 12 hours up to 72 hours.
Animals (n=2) receiving micro-osmotic pump implantation were given EB and
sacrificed at 3 days post-implantation, and animals (n=2) receiving mini- osmotic pump
implantation were given EB and sacrificed at 3 days post-implantation. All brains were
harvested and examined by gross sectioning, as described above.

Evan’s Blue Dye Injection
EB dye was utilized to mark BBB disruption on all rats and brains were examined
when sectioned. EB dye (2% in saline) was delivered at 2ml/kg via the penile vein
within 1 hour prior to sacrifice.

Sacrifice and Perfusion
Euthasol (150 mg/kg plus 19 mg/kg phenytoin) was administered by
intraperitoneal injection following IACUC guidelines.

The rat was transcardially

perfused through a blunt, large-bore needle placed into the left ventricle and positioned
within the ascending aorta. Approximately 400 mL of normal saline (0.9%) was used to
flush the vasculature, followed by approximately 400 mL of fresh 4% paraformaldehyde.
Brains were harvested and placed in fresh 4% paraformaldehyde for 48 hours, after which
they were removed, washed with Millonig’s solution, and stored in the latter solution
until processing for LM or EM studies.
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Light Microscopy Preparation
Selected samples for LM study were cut via vibratome into consecutive 50 µm
thick slices. From each block, approximately 3 slides of 4 sections each were sampled at
-0.4, 0, and +0.4 mm relative to the infusion site (0).

Tissue Preparation for Immunohistochemistry Analysis
Semi-serial coronal sections were used for single label immunohistochemistry
analysis. These sections were rinsed 3 X 10 minutes in PBS and endogenous peroxidase
activity was blocked with 0.3% H2O2 in PBS for 30 min. Sections were rinsed 3 X 10
min in PBS, and pre-incubated for 60 min with 0.2% Triton X (Sigma Chemical Co., St.
Louis, MO) in 10% normal goat serum (NGS)/PBS. The tissue was then incubated
overnight in mouse anti-glial fibrilllary protein (GFAP) antibody at a dilution of 1:1,500
(Zymed Laboratories) in 1% NGS/PBS at a dilution of 1:600. After 3 X 10 min washes
in PBS containing 1% NGS, the sections were incubated in a 1:200 dilution of or
biotinylated anti-mouse rat adsorbed immunoglobulin (diluted 1:200 in 1% NGS/PBS
(Vector, Burlingame, CA) for 60 min followed by 3 X 10 min rinses in PBS. After
incubation in an avidin-biotin peroxidase complex (ABC standard Elite kit, Vector,
Burlingame, CA) at a dilution of 1:200 for 60 min and rinsing in PBS and 0.1 M
phosphate buffer 3 X 10 min, the sections were processed for visualization of the
immunohistochemical complex using 0.05% diaminobenzidine (DAB) (Sigma Chemical
Co., St. Louis, MO), 0.01% hydrogen peroxide, 0.3% imidazole in 0.1 M PBS. Next the
sections were mounted, serially, on gelatin-coated glass slides, dehydrated and coverslipped.
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Qualitative Representation of GFAP Immunoreactivity
Tissue stained for GFAP was visualized using the Nikon E800 M Eclipse
Microscope with SpotRT camera (Diagnostic Instruments), which was used for image
acquisition.

Microscopy was performed at the VCU – Dept. of Anatomy &

Neurobiology Microscopy Facility, supported, in part, with funding from NIH-NINDS
Center core grant (5P30NS047463). Slides stained for GFAP were qualitatively assessed
according to morphological characteristics. At 4x and 20x magnification, the corpus
callosum was inspected for evidence of dark, interconnecting astrocytic processes, the
presence of which was defined as a GFAP increase.

Transmission Electron Microscopy Preparation
Selected samples for electron microscopy (EM) study were taken from parallel
sampling sites as those used in LM preparation. Selected slices were washed with 0.1M
Sorensen's phosphate buffer at 4°C then postfixed with 1% osmium tetroxide in 0.1M
phosphate buffer at 4°C for 1 hour. Samples were then washed with buffer and
dehydrated with a cold ethanol series: 50%, 70%, 80%, and 95%, for 5 minutes each.
Next, slices were dehydrated with 100% ethanol at 20°C, followed by 3 changes of 100%
propylene oxide for 10 minutes each. Slices were placed in a 1:1 propylene
oxide:PolyBed solution for 4 hours, and then transferred to pure PolyBed resin overnight.
Each section was embedded on vinyl slides and placed in a 60°C oven overnight. After
LM examination, sections were chosen and excised from the cortical and deep gray
region for remounting on blocks and further sectioning. Using the LKB 2120
Ultramicrotome, 900Å sections were cut with a diamond knife. Each section was then
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placed on Formvar-coated slotted grids and stained with uranyl acetate and lead citrate
for TEM study. A JEOL JEM-1230 (JEOL USA, Inc.) transmission electron microscope
was used to capture images via the Ultrascan 4000 camera (Gatan, Inc.).
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Magnetic Resonance Imaging
Implantation of Guide Cannula
Rats were anesthetized by intraperitoneal administration of 90 mg/kg ketamine :
10 mg/kg xylazine (10 : 1 mixture of ketamine [100 mg/mL] : xylazine [50 mg/mL]).
Lubricating veterinary ointment was applied to the eyes and the animal was placed on a
heating pad in a stereotactic frame. A 10 mm midline incision was made at the scalp,
centered approximately at bregma. an infusion burr hole was stereotactically marked
3mm lateral, 1 mm posterior to bregma for all in-bore infusions. The first burr hole was
created 3 mm posterior to the infusion mark using a roto-tool and fine drill bit. The burr
hole was manually threaded with a metal screw, the rise of which was calculated and
compared to the thickness of the skull to prevent injury to the brain. A nylon screw
(PlasticsOne, Roanoke, VA) was placed into this hole and the infusion burr hole was then
created. An outer guide cannula (PlasticsOne, Roanoke, VA) containing a stylette was
placed onto the infusion burr hole and temporarily fixed with superglue. Several minutes
following, the stereotactic arm was raised, and dental cement (Hygenic, Akron, OH) was
applied around the base of the guide cannula and nylon screw. Allowing enough time to
set, the incision was then closed with absorbable chromic gut, averaging 6 interrupted
sutures along the length of the incision. The stylette was removed from the guide cannula
and a dummy cap – previously cut to match the length of the guide – was placed into the
guide. Buprenorphine (0.03 mL, 0.3 mg/mL) was then administered subcutaneously
every 12 hours up to 72 hours, with the rat placed under a heat source and monitored until
alert and mobile.
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In-bore Infusion
Each rat to be scanned was either kept under isoflurane anesthesia if imaging was
conducted on the same day as DCA or saline infusion, or anesthetized by intraperitoneal
administration of 90 mg/kg ketamine : 10 mg/kg xylazine (10 : 1 mixture of ketamine
[100 mg/mL] : xylazine [50 mg/mL]) for all subsequent follow-ups. After baseline
scanning, a 6 mm infusion needle (PlasticsOne, Roanoke, VA) was lowered into the
guide cannula such that the tip of the needle was 3 mm below the surface of the brain. A
volume of 9 µL (n=3) of 2.0 mM DCA in saline was infused into the right corpus
callosum at a flow rate of 0.2 µL/min for 45 minutes with one group of rats (n=3).
Animals were scanned for up to 3 hours post-infusion, such that T2-weighted, diffusionweighted, T1-weighted images were taken sequentially every 30 minutes. The infusion
needle remained in the animal for post-infusion scanning and the guide cannula was recapped after the final scan. The rat was then placed under a heat source and monitored
until alert and mobile. One of these animals was received follow-up scanning at 1 day, 5
days, and 7 days post-infusion. A second animal received follow-up scanning at 1 day.
The third died between 2-3 hours post-infusion. After scanning, animals were placed
under a heat lamp and monitored until normal respiration had returned before extubation.
Animals were then monitored until awake and alert before being placed by in the
vivarium.
Imaging Following Stereotactic Infusion
All animals that were examined by MRI following stereotactic infusion were
anesthetized by intraperitoneal administration of 90 mg/kg ketamine : 10 mg/kg xylazine
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(10 : 1 mixture of ketamine [100 mg/mL] : xylazine [50 mg/mL]). Each animal received
was subjected to a single set of T2-weighted, diffusion-weighted, T1-weighted images.
Although described above in the stereotactic infusion section, a brief summary is
provided. From the 9 µL of 2.0 mM DCA infusion group, 2 animals received scaning at
1 day post-infusion. From the 9 µL of 1.0 mM DCA infusion group, 3 animals received
scaning at 1 hour post-infusion and 3 additional animals received scanning at 1 day.
Similarly, 3 animals received scaning at 1 hour post-infusion and 3 additional animals
received scanning at 1 day following infusion of 9 µL of 0.5 mM DCA.
Imaging Placement
Each rat to be scanned was either kept under isoflurane anesthesia for in-bore
infusion, or anesthetized by intraperitoneal administration of 90 mg/kg ketamine : 10
mg/kg xylazine (10 : 1 mixture of ketamine [100 mg/mL] : xylazine [50 mg/mL]) when
scanning occurred following stereotactic infusion and for all subsequent follow-ups.
Each rat was placed in an acrylic imaging tube, secured via plastic ear bars, and fitted
with a surface coil. Images were acquired with a 2.4 T, 40-cm bore magnet (Bruker
Medical, Inc., Billerica, MA) equipped with a 12 cm inner-diameter, actively shielded
gradient insert (maximum gradient strength: 25 G/cm). An actively decoupled RF coil
set was used for RF excitation/reception and was comprised of a 7 cm inner-diameter
“birdcage” design resonator and a 2 cm diameter circular surface coil.
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T2 images
T2-weighted images with echo time (TE) of 100 msec, and repetition time (TR) of
3000 msec, were obtained on 5 contiguous coronal slices 2-mm thick with a resolution of
96 by 96.
EPI DWI
DWI (TR: 1500 msec/ TE: 41msec) images were taken which employed an echo
planar based spin echo sequence appropriately modified to include diffusion-sensitizing
gradients along the readout (horizontal) direction with a duration of 9msec and a gradient
separation of 20 msec. Each data set consisted of 5 coronal slices of the forebrain and
midbrain region, each slice being 2-mm thick with a resolution of 128 by 128 and a 30mm2 field of view. Diffusion weighting factors, or b values of 0 and 1042s/mm2 were
used (maximum gradient strength of 23 G/cm). ADC maps were processed from DWI
images using the MRVision software package (MRVision Co., Winchester, MA).
SE DWI
DWI (TR: 1500 msec/ TE: 39 msec) images were taken which employed a spin
echo sequence appropriately modified to include diffusion-sensitizing gradients along the
readout (horizontal) direction with a duration of 4 msec and a gradient separation of 25
msec. Each data set consisted of 5 coronal slices of the forebrain and midbrain region,
each slice being 2-mm thick with a resolution of 128 by 128 and a 30-mm2 field of view.
Diffusion weighting factors, or b values of 4.2, 160.5, 557.6, and 1195.6 s/mm 2 were
used (maximum gradient strength of 23 G/cm). ADC maps were processed from DWI
images using the MRVision software package (MRVision Co., Winchester, MA).
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T1 images
A two-dimensional T1 imaging series was generated with a spin echo, echoplanar imaging sequence preceded by an inversion recovery preparation period using a
hyperbolic secant inversion pulse. Data was obtained on 3 coronal sections at a thickness
of 2.5mm and slice separation of 3.0mm. Inversion recovery times were: 30, 60, 150,
300, 700, 1300, and 2500 msec.
Data Analysis
Average T1 and ADC values were obtained from regions-of-interest (ROI)
outlined in the corpus callosum from the slice containing the cannula track. T1 Maps
were calculated from the inversion recovery images. These T1 maps were converted to
water maps by means of the following equation (Fatouros and Marmarou 1999) using the
MRVision software:
fw = [T1 / (0.407 + 0.907*T1)]*100
Here fw is the percent water content. This formula is applicable at a field strength of 2.4
T. Mean fw and ADC values from edematous regions for each infusate concentration and
time period were compared to contralateral brain using t-tests and graphical analysis.
Donation of Tumor-Bearing Rats
Brain tissue from T9 glioma-bearing female Fisher 344 (Harlan, Indianapolis, IN)
rats (weighing approximately 120 – 140 grams) was donated by Dr. Zhi-jian Chen. Two
of the animals had been tumor-bearing for 22 days, and one of the animals had been
tumor-bearing for 15 days. Tissue was sectioned on a vibratome and parallel sections
were processed for GFAP and EM as described above for each animal.
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T9 glioma cells were given to Dr. Chen by Dr. Martin Graf (Department of
Neurosurgery, Virginia Commonwealth University, Richmond, Virginia). Cells were
cultured in DMEM supplemented with 10% FBS and non-essential amino acids, as
adherent monolayers at 37oC, and passed biweekly with trypsin in the absence of
antibiotics. Cell lines were routinely screened for mycoplasma contamination (MycoTect,
Gibco BRL). All tissue culture reagents and supplements were obtained from Gibco BRL
(Grand Island, NY) unless noted otherwise. Monolayers of tumor cells were trypsinized,
counted on a hemacytometer and viability was assessed by trypan blue exclusion. Cells
were washed twice in phosphate buffered saline (PBS) and the concentration was
adjusted appropriately (Graf et al. 2005).
Before tissue donation to this project, each rat received implantation of a guide
cannula as described above, and after 24 hours was infused with 5 x 10 4 T9 glioma cells
into the right striatum (Graf et al. 2005). Cells were permitted to grow for 1 week before
MRI scanning to confirm tumor formation. Two animals received follow-up scans up to
21 days post-infusion of T9 cells, and the third received follow-up scans up to 14 days
post-infusion. For follow-up scans, animals were anesthetized as previously described,
but were also administered Gd-DTPA intravenously through the lingual vein before
scanning for enhancement on T1-weighted images. For the purposes of this study, T2weighted images and Gd-enhanced T1-weighted images and were analyzed. All animals
were sacrificed by transcardial perfusion and tissue was fixed with 4% paraformaldehyde
as described above at 1 day after the final follow-up MRI scans. After brains were
harvested, they were donated to this project for aforementioned tissue processing. For
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analysis in this study, qualitative examination was performed on T2-weighted images,
Gd-enhanced T1-weighted images, tissue stained for GFAP, and tissue processed for EM.

Chapter 4
Results

VEGF
Blood-Brain Barrier Integrity
VEGF was infused stereotactically into the striatum, and infusions with micro-and
mini-osmotic pumps were also performed into the cortex.

BBB integrity was then

evaluated by gross sectioning of the brain to visualize EB staining following intravenous
administration. No EB extravasation, as demonstrated in Figure 4-1, A, was observed
ipsilaterally or contralaterally following stereotactic infusion of 0.1 µg/mL VEGF at 1
and 20 hours, 1 µg/mL VEGF at 1 hour, and 5 µg/mL VEGF at 1 hour. Similarly, no
ipsilateral or contralateral EB stain was observed following 1 µg/mL VEGF infusion both
through micro-osmotic pumps after 3 days, and mini-osmotic pumps after 5 days. It was
also noted that needle tracts and cannula tracts (ipsilateral) from all infusions showed no
evidence of EB extravasation.
Hematoxylin and Eosin Staining
Hematoxylin and Eosin (H&E) stains were also performed on representative
tissue from all stereotactic infusion parameters by the department of anatomical
pathology. No Virchow-Robins spaces or other evidence of fluid extravasation was
48
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Figure 4-1. Representative images showing a brain with no Evan’s Blue Dye
extravasation (A) following VEGF infusion compared to a brain infused with 2.0mM
DCA where Evan’s Blue Dye extravasation was present (B). Blue color in (B) shows
extravasated Evan’s Blue bound to serum proteins in the corpus callosum on the left side
of the image.
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Figure 4-2. Photomicrograph of H&E-stained ipsilateral striatum following stereotactic
infusion of 0.1 µg/mL VEGF. Red blood cells in needle tract noted with arrow.
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observed ipsilaterally or contralaterally in any tissue sample. Needle tract containing red
blood cells was observed ipsilaterally in representative tissue for 1 hour post-infusion of
0.1 µg/mL VEGF (Figure 4-2).

Deoxycholic Acid
Blood-Brain Barrier Integrity
EB extravasation was observed by gross brain sectioning in the ipsilateral corpus
callosum following 30-, 45- and 60-minute infusion of 2.0 mM DCA (Figure 4-1, B).
For this same concentration, 30- and 60- minute infusion into the striatum also
demonstrated EB extravasation. Gross brain sectioning of 1.0 mM DCA infusion did not
show EB extravasation in ipsilateral corpus callosum (30-minute infusion), but 30-minute
infusion of this same concentration into the striatum did show EB extravasation
ipsilaterally. However, EB extravasation was observed at 1 hour post-infusion of 1.0 mM
DCA in the ipsilateral corpus callosum in sections containing needle tract when
sectioning tissue on the vibratome; it was thereby determined that 45-minute infusion of
1.0 mM DCA caused EB extravasation. 1 day post-infusion of 1.0 mM DCA, no EB
extravasation was observed.

No EB extravasation in the ipsilateral or contralateral

corpus callosum was observed following 45-minute infusion of 0.5 mM DCA upon gross
sectioning or vibratome sectioning at 1 hour and 1 day post-infusion.
Stereotactic saline infusion into the corpus callosum over 90 minutes did not show
EB extravasation upon gross sectioning or vibratome sectioning when animals were
sacrificed at 1 hour post-infusion.

54

Table 4-1. Table demonstrating observed EB extravasation in the corpus callosum for
groups of rats receiving 9 µL of 0.5 mM, 1.0 mM, or 2.0 mM DCA infusion when
examined at 1 hour and 1 day. No observed EB staining is indicated by (-). Observed
EB staining is indicated by (+).
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1 Hour

1 Day

-

-

Ipsilateral
0.5 mM DCA

-

-

Ipsilateral
1.0 mM DCA

+

-

Ipsilateral
2.0 mM DCA

+

-

Contralateral

56

Magnetic Resonance Imaging
T2 Imaging
T2 images from representative animals are presented in Figure 4-3, showing 1
hour and 1 day post-infusion of 0.5 mM, 1.0 mM, and 2.0 mM DCA. Infusion of 0.5 mM
DCA produced hyperintensity in the ipsilateral corpus callosum at 1 hour post infusion.
Lateral extension of the hyperintensity from the site of infusion was observed as seen in
the 2.0 mM DCA group described above; no medial extension across the midline was
observed.

By 1 day, no ipsilateral hyperintensity was apparent in any animals.

Contralaterally, no hyperintensity for the same area of the corpus callosum was apparent
in any animal for each time point.
Infusion of 1.0 mM DCA produced hyperintensity in the ipsilateral corpus
callosum at 1 hour post infusion. Lateral extension of the hyperintensity from the site of
infusion was observed as seen in the 2.0 mM DCA group described above; no medial
extension across the midline was observed. By day 1, similar ipsilateral hyperintensity
was observed in 1 animal but not in the other two. In addition, hyperintensity along the
needle tract was observed in this animal and another animal.

Contralaterally, no

hyperintensity for the same area of the corpus callosum was apparent in any animal for
each time point.
Following 45-minute infusion of 2.0 mM DCA, T2 hyperintensity was observed
in the ipsilateral corpus callosum in all animals at 1 hour. The observed hyperintensity
was localized to the corpus callosum such that the hyperintensity extended primarily in a
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Figure 4-3. T2-weighted MR images following infusion of 0.5 (A, B), 1.0 (C,D), and
2.0 (E, F) mM DCA at 1 hour (A, C, E) and 1 day (B, D, F). At 1 hour post-infusion, all
concentration groups display T2 hyperintensity in the ipsilateral (right side of image)
corpus callosum. Only the 2.0 mM DCA group displays ipsilateral T2 hyperintensity at 1
day post-infusion.
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lateral fashion from the infusion site. However, in one animal there was medial extension
slightly beyond the midline axis of the brain in addition to the lateral extension. By 1
day, the ipsilateral corpus callosum also exhibited hyperintensity, and was confined to a
lateral extension from the site of infusion without cross of the midline. Contralaterally, no
hyperintensity for the same area of the corpus callosum was apparent in any animal for
each time point.
Water Content
The location of each region selected for water content measurement was dictated
by the area of T2 hyperintensity ipsilaterally and by the symmetrical region on the
contralateral side. Graphs of water content for each DCA dose are seen at the tops of
Figure 4-4 for 1 hour post-infusion and Figure 4-5 for 1 day post-infusion.
Infusion of 0.5 mM DCA over 45 minutes produced higher average water content
in the ipsilateral corpus callosum (76.0%) relative to contralateral 71.7%) but the
difference in these values did not attain significance (p=0.088). For this same treatment,
the ipsilateral and contralateral corpus callosum did not show a significant difference in
water content 1 day post-infusion. Average values for ipsilateral and contralateral were
72.5% and 72.5%, respectively.
Infusion of 1.0 mM DCA over 45 minutes produced significantly higher
(p=0.014) ipsilateral water content of 77.1% compared to 71.8% of the contralateral
corpus callosum at one hour post-infusion.

1 day following this same treatment,

ipsilateral and contralateral water contents were 76.4% and 73.4%, respectively, but the
difference in these values did not attain significance.
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Figure 4-4. Graphs displaying percent water (top) and ADC values (bottom) for the
contralateral and ipsilateral corpus callosum at 1 hour post-infusion of DCA. The
ipsilateral corpus callosum for 1.0 and 2.0mM DCA has significantly higher percent
water, indicating the presence of edema. Furthermore, all ipsilateral ADC values are
significantly higher than contralateral, suggesting a predominance of vasogenic edema
following 1.0 and 2.0mM DCA infusion. The ipsilateral corpus callosum following
0.5mM DCA infusion does not demonstrate significant increase in percent water content,
but does show significant increase in ADC.

61

62

Figure 4-5. Graphs displaying percent water (top) and ADC values (bottom) for the
contralateral and ipsilateral corpus callosum at 1 day post-infusion of DCA. The
ipsilateral corpus callosum for 2.0mM DCA has significantly higher percent water,
indicating the presence of edema. Furthermore, significantly higher ADC values for this
group suggest the predominance of vasogenic edema. The 0.5 and 1.0 mM DCA groups
show no significant increase in percent water or ADC.
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Following in-bore (infusion inside the MRI on cannulated animals, as previously
described in the methods section) 45-minute infusion of 2.0 mM DCA, water content of
the ipsilateral corpus callosum was increased significantly (p=0.035, n=3) relative to the
contralateral corpus callosum at 1 hour post-infusion. Average ipsilateral water content
was 76.1% compared to 70.9% for contralateral. One of these animals was also used in
conjunction with two additional animals that received 45-minute stereotactic infusions on
the benchtop (as used in 0.5 mM and 1.0 mM DCA infusions) of 2.0 mM DCA to assess
water content and ADC values 1 day post-infusion. At this time point, water content of
the ipsilateral corpus callosum was 77.3%, which was significantly higher (p=0.0041)
than contralateral at 72.0%.
Apparent Diffusion Coefficient
The location of each region selected for ADC measurement was the same as those
used to measure water content, as dictated by T2 imaging. Graphs of ADC for each DCA
dose are seen at the tops of Figure 4-4 for 1 hour post-infusion and Figure 4-5 for 1 day
post-infusion.
Following 0.5 mM DCA infusion, ADC of the ipsilateral corpus callosum was
significantly higher (902 cm2/sec x 10-6 and 647 cm2/sec x 10-6, respectively; p=0.030)
than contralateral. Ipsilateral and contralateral ADC measurements were not significantly
different at 1 day. Average ipsilateral and contralateral ADCs were 723 cm2/sec x 10-6
and 702 cm2/sec x 10-6, respectively.
For the 1.0 infusion group, the changes in ADC occurred in a similar fashion to
water content changes. Average ADC of the ipsilateral corpus callosum (834 cm2/sec x
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10-6) was significantly higher (p=0.036) at 1 hour post-infusion than contralateral (663
cm2/sec x 10-6). Measurement at 1 day showed average ADC of the ipsilateral corpus
callosum to be higher than contralateral, but the difference in these values did not attain
significance. Average ipsilateral and contralateral ADCs were 811 cm2/sec x 10-6 and
704 cm2/sec x 10-6, respectively.
ADC for the 2.0 mM DCA infusion group were significantly higher in the
ipsilateral corpus callosum relative to contralateral at both 1 hour (p=0.0049) and 1 day
(p=0.0013). Average ipsilateral and contralateral ADCs at 1 hour were 945 cm2/sec x 106

and 728 cm2/sec x 10-6, respectively, and at 1 day were 955 cm2/sec x 10-6 and 710

cm2/sec x 10-6, respectively.
GFAP Staining
In the corpus callosum contralateral to infusion, no difference in GFAP staining
was observed between 1 hour and 1 day post-infusion for all doses of DCA. Further, no
morphological characteristics of GFAP upregulation were visible.

Cell bodies and

astrocytic processes were occasionally visible, and no interconnecting processes were
observed. The rats receiving saline infusion showed similar GFAP staining in the
contralateral and ipsilateral corpus callosum, both of which were similar to contralateral
corpus callosum GFAP staining in DCA-infused animals. Figure 4-6 shows GFAP
staining in representative photomicrographs of each dose and time parameter at 4x
magnification. Figure 4-7 shows 20x magnification of the same images seen in Figure
4-6.
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The ipsilateral corpus callosum following 0.5 mM DCA displayed no evidence of
GFAP upregulation at both 1 hour and 1 day post-infusion. The region of interest did not
appear darker at 4x magnification, and at 20x magnification no morphological difference
relative to control or ipsilateral corpus callosum outside of the region was observed.
GFAP staining within the ipsilateral region of interest following 1.0 mM DCA
was no different from contralateral at 1 hour post-infusion, both at 4x and 20x
magnification.

At 1 day, dark GFAP staining was observed when viewed at 4x

magnification, and visualization at 20x magnification showed dark staining but no
interconnecting astrocytic foot processes.
Ipsilateral to infusion of 2.0 mM DCA, astrocytes of the corpus callosum
displayed morphological characteristics of GFAP upregulation at both 1 hour and 1 day
post-infusion within the same region of interest as that of MRI studies.

At 4x

magnification, dark GFAP staining was observed in a similar region to that of T2
hyperintensity.

Long foot processes were visible and highly interconnecting at 20x

magnification.

Outside of this region on the ipsilateral side, the callosum was no

different from control.
Electron Microscopy
Parallel tissue samples taken from each brain used for GFAP immunohistochemistry were prepared for electron microscopy. Briefly, these were ipsilateral and
contralateral corpus callosum samples taken from animals sacrificed 1 hour and 1 day
post-infusion of 0.5 mM, 1.0 mM and 2.0 mM DCA.
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Figure 4-6. Representative tissue stained for GFAP showing dose-dependence of the
corpus callosum to 0.5 (C,D), 1.0 (E,F), and 2.0 (G,H) mM DCA infusion compared to
contralateral (A,B) at 1 hour (A, C, E, G) and 1 day (B, D, F, H) post-infusion.
Increased GFAP staining is present in (F), (G), and (H). Images taken at 4x
magnification.
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Figure 4-7. Representative tissue stained for GFAP showing dose-dependence of the
corpus callosum to 0.5 (C,D), 1.0 (E,F), and 2.0 (G,H) mM DCA infusion compared to
contralateral (A,B) at 1 hour (A, C, E, G) and 1 day (B, D, F, H) post-infusion. Large
presence of cell bodies with few interconnections visible in (D). Dark background
staining with few astrocytic processes are seen in (F). Prominent, interconnecting
astrocytic processes in (G) and (H) produce a spider-web appearance. Images taken at
20x magnification.
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Contralateral corpus callosum tissue samples taken from both 1 hour (Figure 4-8)
and 1 day post-infusion (Figure 4-9) of all three DCA concentrations showed evidence of
normal, healthy tissue ultrastructure.

Myelin closely surrounded neurons, and close

apposition of perivascular astrocytic endfeet to blood vessels was observed.

No

perivascular spaces were observed, nor was there other evidence of ECS expansion.
Further, blood vessel morphology showed no abnormalities. Intracellular organelles such
as smooth endoplasmic reticulum (SER) were observed within the perivascular astrocytic
endfeet without large electron-lucent areas indicative of swelling. Glial somata did not
show evidence of swelling, either. Neural filaments were apparent and not compacted
both at the node of Ranvier and within the intermodal segment.

Intra-axonally,

mitochondria displayed normal cristae and no evidence of impaired axonal transport was
observed. Around the node, myelin paranodal loops were closely apposed to each other
and to the paranodal axon segment. Additionally, myelin ensheathment of the internodal
segments of the axons was observed.
Only two ultrastructural differences were observed in the ipsialateral corpus
callosum following 0.5 mM DCA at 1 hour post-infusion (Figure 4-10) relative to
contralateral.

Astrocytic endfeet surrounding blood vessels appeared swollen;

intracellular areas with little presence of organelles comprised the swollen appearance.
However, astrocytic endfeet tightly apposed blood vessels as seen contralaterally. In
addition, blood vessel morphology was normal relative to contralateral, except luminal
pinocytic vesicles were observed inside blood vessels. Myelin and neurons displayed no
differences from
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Figure 4-8. Electron micrograph images of contralateral corpus callosum at 1 hour postinfusion of DCA. A demonstrates a blood vessel with the visible lumen (“L”). Thick
arrow indicates a neuron in cross section with normal myelin ensheathment and
axoplasm. B demonstrates a node of Ranvier ensheathed by tight, apposing paranodal
loops (thick arrow). Small arrow in A and B indicate artifactual space.
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Figure 4-9. Electron micrograph images of contralateral corpus callosum at 1 day postinfusion of DCA. A demonstrates a blood vessel. Thin. arrow indicates a neuron in cross
section with normal myelin ensheathment and axoplasm. Thick arrow demonstrates
normal intracellular components of an astrocytic endfoot. B demonstrates a node of
Ranvier ensheathed by tight, apposing paranodal loops (thin arrow).
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contralateral at the node, paranode, or internode. At 1 day post-infusion of 0.5 mM DCA
(Figure 4-11), the ipsilateral corpus callosum displayed the same ultrastructural
characteristics as that of 0.5 mM DCA infusion at 1 hour. Perivascular astrocytic endfeet
were swollen but tightly apposed to blood vessels, which were similar to contralateral.
Myelin and neurons displayed no differences from contralateral, as well. No pinocytic
vesicles were observed.
Ipsilaterally at 1 hour post-infusion of 1.0 mM DCA (Figure 4-12), ECS
expansion was evident and perivascular spaces were observed, as well as swollen
perivascular astrocytic endfeet. Pinocytic vesicles appeared on the lumen of some blood
vessels. Proximal to the needle tract, intra-axonal electron-dense areas were observed
inside of some neurons indicating impaired axonal transport, although others displayed
features similar to contralateral. These electron densities were observed in the internode
and at the node, but no blebbing at the node was observed. In addition, the myelinneuron interface was no different from contralateral. Regions lateral to the needle tract
but still within the area identified as hyperintense by MRI T2-weighted imaging
displayed the ECS expansion and swollen perivascular astrocytic endfeet, but neurons
were similar to those observed contralaterally.

Normal intracellular organelles and

axoplasm, no blebbing at the nodes, and normal myelin and axon structural features were
apparent throughout the axons.
1 day following 1.0 mM DCA infusion (Figure 4-13), ipsilateral ultrastructural
differences relative to contralateral were observed. Evidence of ECS expansion was
observed in some samples but not others, although swollen perivascular astrocytic
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Figure 4-10. Electron micrograph images of ipsilateral corpus callosum at 1 hour postinfusion of 0.5 mM DCA. A demonstrates a blood vessel. Arrow indicates a pinocytic
vesicle. Asterisk (*) demonstrates swelling with a perivascular astrocytic end foot. B
demonstrates a normal node of Ranvier.
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Figure 4-11. Electron micrograph images of contralateral corpus callosum at 1 day postinfusion of 0.5 mM DCA. A demonstrates a blood vessel. Asterisk (*) demonstrates
swelling with a perivascular astrocytic end foot. B shows a normal node of Ranvier.
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endfeet apposed to blood vessels of normal morphology were observed.
vesicles were visible, as well.

Pinocytic

Nodes displayed normal axoplasm and morphology.

Internodes and paranodes displayed normal ensheathment by myelin as well as normal
organelles, and no intra-axonal electron-dense areas were observed.
When a concentration of 2.0 mM DCA was infused, multiple ultrastructural
differences existed ipsilaterally relative to contralateral at 1 hour post-infusion (Figure 414). Tissue proximal to the needle tract was in poor condition after processing, but tissue
in areas displaying heavy GFAP upregulation were able to be observed. ECS expansion,
perivascular spaces, and swelling of perivascular astrocytic endfeet were all observed.
Pinocytic vesicles were observed on the luminal face of some blood vessels. Examples
of nodal blebbing were observed, although normal myelin ensheathment to the axon was
observed. No intra-axonal electron-dense bodies or were observed but some abnormal
mitochondrial cristae were observed.
Ipsilateral to infusion at 1 day following 2.0 mM DCA infusion (Figure 4-15),
ECS expansion and perivascular spaces were observed. Swollen perivascular astrocytic
endfeet were also present, as were interendothelial vacuolizations within swollen
endothelial cells. Intra-axonal clustering of organelles and disruption of the cellular
membrane was observed in some axons, although others displayed no difference from
contralateral. Further, some myelin degeneration was observed although myelin tightly
apposed other axons.
Following infusion of each concentration of DCA, no ultrastructural abnormalities
were observed in glial somata at 1 hour or 1 day post-infusion, similar to control.
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Figure 4-12. Electron micrograph images of ipsilateral corpus callosum at 1 hour postinfusion of 1.0 mM DCA. A demonstrates a blood vessel. Arrow indicates a normal
neuron in cross section. Perivascular space noted by “P.” B demonstrates a normal node
of Ranvier, but ECS expansion is evident (“E”).
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Figure 4-13. Electron micrograph images of ipsilateral corpus callosum at 1 day postinfusion of 1.0 mM DCA. A demonstrates a blood vessel. Asterisk (*) demonstrates
swelling with a perivascular astrocytic end foot. B demonstrates a normal node of
Ranvier.
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Figure 4-14. Electron micrograph images of ipsilateral corpus callosum at 1 hour postinfusion of 2.0 mM DCA. A demonstrates a blood vessel surrounded by ECS expansion
(“E”). Thick arrow indicates healthy neuron, whereas think arrow indicates a
demyelinating axon. B demonstrates a node of Ranvier with blebbing (arrow).
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Figure 4-15. Electron micrograph images of ipsilateral corpus callosum at 1 day postinfusion of 2.0 mM DCA. A demonstrates a swollen pericyte (arrow) surrounded by ECS
expansion (“E”). Thick arrow indicates a necrotic neuron with electron-dense axoplasm.
B demonstrates a blood vessel and swollen astrocytic end foot (*).
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T9 Glioma-Bearing Rats
Consistent results were observed among all tumor-bearing rats, and as with
stereotactic DCA infusions, the region of interest was the corpus callosum ipsilateral to
tumor.
On MRI (Figure 4-16), Gd-enhanced T1-weighted imaging (Figure 4-16, A)
qualitatively showed tumor boundaries localized to the right striatum striatum, and T2weighted imaging (Figure 4-16 B) showed peritumoral hyperintensity surrounding the
tumor mass and within the ipsilateral corpus callosum.

No T2 hyperintensity was

observed in the contralateral corpus callosum. Mass effect was observed on in both T1weighted and T2-weighted images.
GFAP immunohistochemistry qualitatively demonstrated GFAP upregulation
ipsilateral to the tumor in the corpus callosum at 4x and 20x magnification, as seen by
dark color coloring and interconnecting astrocytic cell processes.

Contralateral

hemispheres showed no evidence of GFAP upregulation. Images of tissue stained for
GFAP can be seen in Figure 4-17.
EM analysis qualitatively demonstrated no ultrastructural abnormalities in the
corpus callosum contralateral to the tumor (Figure 4-18, A). Ipsilaterally (Figure F-18,
B, C, D), however, ultrastructural differences in the corpus callosum relative to
contralateral were observed. ECS expansion was evident and some perivascular spaces
were observed.
morphology.

However, axons and myelin displayed normal ultrastructural
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Figure 4-16. Parallel MRI Gd-enhanced T1-weighted (A) and T2-weighted (B) images
of coronal slices from a rat brain at 20 days post-implantation of T9 glioma. Tumor
boundary is visible in hypertensities visible in both both A and B, particularly in the
bottom middle slice of each image set. Top left and top middle slices in B demonstrate
hyperintensities localized to the corpus callosum.
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Figure 4-17. Photomicrographs of coronally-sectioned tissue stained for GFAP from
animal implanted with T9 glioma. Ipsilateral is seen in A (4x) and B (20x), and
contralateral is seen in C (4x) and D (4x). Contralateral corpus callosum displays similar
qualitative staining profile as observed in the contralateral corpus callosum following
DCA infusions. Ipsilateral shows dark staining (A) and evident spider-web appearance in
the cellular morphology (B).
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Figure 4-18. Electron micrograph images of contralateral (A) and ipsilateral (B, C, D)
corpus callosum in animals implanted with T9 gliomas. Thick arrows in A, C, and D
demonstrate normal neuronal and myelin ultrastructure. B and D demonstrate blood
vessels (“L” indicates lumen). Thin arrow in B demonstrates healthy endothelial cell and
“E” indicates ECS expansion. Large perivascular space (“P”) exists in D.
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Chapter 5
Discussion

VEGF
The literature documents VEGF as a potent cytokine capable of inducing vascular
leakage followed by angiogenesis (Folkman et al. 1995). Despite these findings, VEGF
infusion did not produce noticeable extravasation of serum proteins in this study. Serum
protein extravasation was evaluated by visualization of EB in the infusion site following
intravenous EB administration and transcardial perfusion. EB binds irreversibly to serum
proteins, and one would expect that protein extravasation across a compromised BBB
would be visible when EB is bound. The lack of visible blue staining of the parenchyma
in any of the parameters tested suggests that stereotactic infusion of VEGF does not
induce significant BBB breakdown.
EB extravasation is a common method of evaluating BBB breakdown and
albumin extravasation (Shukla 2006), but others have evaluated BBB breakdown
following VEGF infusion using different techniques. In one study (Dobrogowska et al.
1998), albumin extravasation and BBB integrity were evaluated 10 minutes, 30 minutes
and 24 hours following stereotactic infusion of 10 µL of 4µg/mL VEGF into the mouse
cortex; these same evaluations were performed on untreated animals and at 10 and 30
97
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minutes following stereotactic saline infusion. Ultrastructural analysis by transmission
electron microscopy (TEM) was performed and immunogold staining for albumin
permitted its quantification using TEM. The authors found small amounts of albumin in
the subendothelial space and perivascular neuropil of all saline-infused animals, which
was quantitatively similar to albumin present in untreated animals.

VEGF infusion

caused an increase of albumin extravasation to the subendothelial space but not to the
perivascular neuropil. In addition, ultrastructural analysis of the endothelial cells showed
small differences in their structure compared to saline and normal brain but no tight
junction variability.
The experiment performed by Dobrogowska et al. (1998) is similar to stereotactic
infusions performed for this thesis of 20 µL of 1 and 5 µg/mL VEGF into the striatum,
after which animals received EB and were sacrificed 1 hour post-infusion. Due to the
closeness of concentrations and time parameters, the larger volume of infusion, and the
fact that EB binds albumin irreversibly (Shukla 2006), one would expect that albumin
would extravasate and be visible by EB. Because we did not observe EB extravasation in
the area of infusion upon sectioning, this finding suggests that stereotactic infusion of
VEGF did not produce significant BBB disruption and albumin extravasation, which
contradicts the findings of Dobrogowska et al. However, there may be a difference in
sensitivity between gross visualization of EB and immunogold visualization of albumin
at the ultrastructural level.

Dobrogowska et al. observed significant albumin

extravasation in the subendothelial space but not in the perivascular neuropil
(Dobrogowska et al. 1998). If albumin localizes only to this specific area and does not
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extend to the surrounding neuropil following VEGF infusion then EB staining localized
to this small region might not be visible grossly. This would suggest that immunogold
labeling of albumin is a more sensitive technique for visualizing extravasated albumin
than grossly viewing EB.
Another interesting aspect of the paper is that the authors neither stated nor
implied that saline and VEGF infusions induced edema nor did they show perivascular
spaces at the ultrastructural level (Dobrogowska et al. 1998), which are seen in the
albumin infusion model of edema (Ohata et al. 1990).

The authors showed some

alterations of the endothelial cell morphology but no alteration of tight junctions
(Dobrogowska et al 1998). Although VEGF infusion by these authors caused albumin
extravasation and altered endothelial cell morphology, the lack of morphological
characteristics of edema could mean that the amount of serum protein extravasation was
insufficient to cause edema. Determination of water content or another evaluation of
fluid extravasation for the infused tissue could show whether the BBB alteration and
albumin extravasation was sufficient to produce edema.
Some of our other VEGF experiments utilized micro-and mini-osmotic pumps to
allow continuous infusion of 1 µg/mL VEGF into the rat cortex for 3 and 5 days,
respectively. Again, no EB extravasation was observed grossly in the infused region
upon sectioning.

In a similar experiment, Croll et al. (2004) showed increased

inflammatory response to VEGF infusion by micro-osmotic pump that increased over 7
days.

Dose-dependent IgG and leukocyte extravasation, as well as altered vascular

morphology were observed in the rat cortex infused for 1-7 days with 2.5, 5, 10 and 20
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µg/mL VEGF relative to PBS using the same model micro-osmotic pumps as in our
experiment. Immunohistochemical stains for leukocytes, IgG, and endothelial cells were
used to visualize them by light microscopy. Additionally, Western blotting quantitatively
revealed IgG and ICAM-1, an adhesion molecule necessary for diapedesis by leukocytes,
upregulation.
The lower two concentrations used by Croll et al. were within the same order of
magnitude but larger nonetheless than those used in our experiment. A dose-dependence
was observed (Croll et al. 2004) and therefore the 1 µg/mL VEGF infusion used in our
experiment would not be expected to induce the magnitude of effects seen by Croll et al.
The authors noted modest leukocyte and IgG extravasation 1 day and robust
extravasation on days 3-7 for all concentrations but with a dose-dependence on the
intensity of staining at each time point. Performance of this experiment with 1 µg/mL
VEGF would tell either that this concentration was sufficient to induce leukocyte and/or
IgG extravasation, or that a minimum dose for extravasation exists between 1 and 2.5
µg/mL VEGF. If 1 µg/mL VEGF is sufficient to induce these effects as seen by the
methods of Croll et al., then we could conclude that gross EB visualization is a lesssensitive tool for evaluation of vascular leakage than immunostaining for IgG and
leukocytes. Further, if 1 µg/mL VEGF infusion is not sufficient to induce vascular
leakage, then gross EB evaluation should be performed on the higher concentration
parameters and compared to determine if this technique is as sensitive as
immunohistochemistry for IgG and leukocytes.
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The issue of specificity may also be a concern when comparing our methods to
those of Croll et al. (2004).

EB binds with high affinity to albumin (Radius and

Anderson 1980), and because albumin is the predominant protein in plasma (Vert and
Domurado 2000), we measured predominantly albumin extravasation. Other authors
have measured both albumin extravasation by EB visualization with fluorescence
microscopy or other techniques, and IgG extravasation by immunohistochemistry for a
given experiment to evaluate vascular permeability (Shimamura et al. 2006; Chen et al.
2008).
VEGF is known for its role as a BBB permeability factor in the inflammatory
response (Proescholdt et al. 1999), so VEGF-induced vascular leakage could show
preference for components of the immune system. Dobrogowska et al. (1998) showed
that VEGF infusion permitted albumin extravasation but did not show evidence of
edema, suggesting that the amount of albumin leakage subsequent to stereotactic VEGF
infusion was insufficient to cause edema. Repetition of this experiment to determine
whether or not an immune response occurred would be useful, as Croll et al. similarly did
not observe edema within 24 hours of exogenous VEGF introduction. In these
experiments (Croll et al. 2004), the authors showed IgG and leukocyte extravasation with
as little as 1 day of continuous infusion but morphological evidence of edema was
evident only after 7 days of continuous infusion. As mentioned above, repetition of the
Croll et al. experiments could point to the presence or absence of a sensitivity difference
between gross EB visualization and immunohistochemistry techniques, but they may also
indicate a specificity preference for immune system components during VEGF-induced
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vascular leakage.

Croll et al. even showed that ICAM-1 was upregulated, which

specifically permits leukocytes to extravasate during diapedesis (Croll et al. 2004). For
repetition of these experiments, one would need to use techniques with similar sensitivity
to measure IgG and albumin extravasation. In addition, repetition of the Dobrogowska et
al. (2004) experiments with staining for IgG compared to that of albumin would provide
further information on the question of preferential BBB permeability in VEGF-induced
vascular leakage.
The purpose of this study was to determine if VEGF could be used as a model of
pure vasogenic edema in the rat brain. We first set out to decide if VEGF could induce
BBB breakdown and serum protein extravasation before investigation of water content.
No evidence of serum protein extravasation using gross EB visualization was observed
after multiple parameters of VEGF infusion followed by intravenous EB administration,
and therefore no analysis of water content was performed. Because similar experiments
did show evidence of serum protein extravasation using different evaluation techniques,
further experiments as described above should be performed to compare the sensitivities
of these techniques, and to investigate the specificity of vascular leakage before
attempting experiments to evaluate edema.

Deoxycholic Acid
Contralateral Control
All brain infusions were performed in the right cerebral hemisphere of the rat
brains. The left cerebral hemisphere served as a control because no effect was expected
or observed contralateral to the infusion for the same brain region. For visualization of
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EB staining, no EB was present in the contralateral symmetrical region so internal
controls were used for comparison.
On MRI, observed brain water content of the contralateral corpus callosum was
consistent for each experimental parameter, and was similar to human brain as seen by
Fatouros and Marmarou (1999); human corpus callosum is approximately 68% water.
These authors attributed the presence of myelin, a lipid, in white matter to the smaller T1
signals relative to greater T1 signals observed in gray matter, which had water content of
77.1% and 80.3% in representative regions (lentiform and caudate nuclei, respectively).
This suggests that the contralateral corpus callosum is an adequate control for comparison
with the ipsilateral corpus callosum for MRI experiments.
Two animals received stereotactic saline infusions into the corpus callosum, and
were given EB and sacrificed 1 hour post-infusion.

No EB extravasation occurred

ipsilateral or contralateral to infusion. In addition, GFAP staining ipsilateral to infusion
for these animals showed no difference from contralateral following saline infusion, and
both sides displayed no difference from each contralateral corpus callosum from DCAinfused animals. This suggests that the contralateral corpus callosum is an appropriate
control for comparison with the ipsilateral corpus callosum in EB and GFAP
experiments.
On the EM, consistency between all contralateral corpus callosum samples from
treated animals at both 1 hour and 1 day was observed. Morphologic observations of the
contralateral samples were consistent with normal ultrastructural characteristics such as
tight ensheathment of axons by myelin, tightly-apposed paranodal loops (Dupree et al.
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2005), apposition of perivascular astrocytic end feet to pericytes and endothelial cells
(Ohata et al. 1990), lack of glial and axonal swelling (Singleton et al. 2002), and lack of
NF compaction (Gallyas et al. 2006). Further, glial somata all displayed normal and
consistent ultrastructure for both time points.

These ultrastructural observations

permitted the use of internal controls for EM experiments.
Evaluation of Edema
As described in the introduction, exogenous DCA application to the brain has
been shown to disrupt the BBB (Greenwood et al. 1991), allowing serum albumin
extravasation and the formation of vasogenic edema (Seiffert et al. 2004). However,
these studies did not thoroughly examine the purity of vasogenic edema. In experiments
by Greenwood et al., no examination of cellular swelling was performed following
intracarotid DCA perfusion (Greenwood et al. 1991).

Seiffert et al. showed EB

extravasation, increased T1 and T2 signal intensities on MRI, and GFAP increase in
response to cortical perfusion with DCA (Seiffert et al. 2004). ADC measurements
would tell whether the increased tissue water content occurred predominantly in the
intracellular or extracellular compartments of the tissue. In fact, the GFAP increase, as a
marker for astrocytic reactivity, suggests the presence of cellular edema, although this
increase did not occur immediately, and therefore investigation into the exact location of
the excess fluid would permit definition of the edema as purely vasogenic or cytotoxic, or
a heterogeneous mixture of each.
Our studies utilized multiple techniques to provide specific information regarding
tissue fluid components, tissue water content, location of excess tissue fluid, and
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ultrastructural analysis following infusion of 0.5 mM, 1.0 mM and 2.0 mM DCA after 1
hour and 1 day. From the results of these individual techniques, an assessment of edema
formation and edema type was made for each of these 6 parameters.

EB staining

suggested that extravasated serum proteins and fluid contributed to any observed edema.
Edema was defined as a significant increase in water content on MRI in the region of
hyperintensity; if this was observed, a significant ADC increase was then required to
show the predominance of vasogenic edema. ADC increase indicates a predominant
increase in extracellular fluid, but this signal may represent average water diffusivity
throughout the tissue.

Therefore further examination of the tissue is necessary to

determine if there is intracellular swelling in addition to interstitial fluid accumulation
when water content and ADC are significantly increased. GFAP upregulation indicated
astrocytic cell reaction, along with indications of both interstitial fluid accumulation and
cellular swelling that were observed by EM.
0.5 mM DCA
It has previously been shown that DCA concentrations below 1.0 mM did not
disrupt BBB function when perfused through the carotid artery in exsanguinated rats, as
evidenced by no observed extravasation of intravenous [ 14C]mannitol (Greenwood et al.
1991).

Greenwood et al. also demonstrated in this study that the concentration of

[14C]mannitol did not contribute to BBB disruption. The study further showed that DCA
concentrations below 1.5 mM did not cause “lytic action” on RBCs (Greenwood et al.
1991), which was consistent with our ultrastructural observations on the effects of a
similar range of concentrations of DCA infused intraparenchymally. In our study, no EB
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staining was observed following 0.5 mM DCA infusion both at 1 hour and 1 day. This
result suggested that no functional disruption of the BBB occurred, which is consistent
with the aforementioned study (Greenwood et al. 1991). As a whole, our results taken in
the context of the other studies cited suggest that any potential increase in tissue water
content following 0.5 mM DCA consists solely of the infusate fluid.
At 1 hour, ipsilateral T2 hyperintensity was observed in the corpus callosum, but
average water content increased without attaining significance, which demonstrated that
significant edema was not present. Interestingly, the significant increase in ADC showed
an increase in extracellular fluid, although no perivascular spaces or other evidence of
ECS expansion was observed ultrastructurally.

In fact, the observation of swollen

astrocytic end feet without evidence of ECS expansion suggested the contrary - that
cellular fluid accumulation occurred. However, GFAP upregulation was not observed,
suggesting that the presence of infusate fluid did not cause the astrocytes to become
reactive.

Therefore this ultrastructural observation of cellular fluid accumulation

indicates that the astrocytes made an insignificant contribution to fluid clearance, as
further supported by the observation that glial somata did not appear swollen. This
would be expected based on documented observations that astrocytes uptake extravasated
proteins in vasogenic edema, thereby lowering the extracellular oncotic pressure
(Stummer 2007).

The insignificance of the observed water content increase does

correlate with both the lack of GFAP upregulation and the lack of evidence for
ultrastructural ECS expansion.

In addition, no ipsilateral GFAP upregulation was

observed at 1 day despite swelling of perivascular astrocytic end feet. No difference
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between contralateral and ipsilateral was observed by MRI, and no ultrastructural
observations of ECS expansion, perivascular spaces, glial somata, or neuronal pathology
were observed, as well.
Taken together, these results suggest that the observed swellings due to 0.5 mM
DCA infusion made an insignificant contribution to overall distribution of infusate.
Further, the results of this experiment suggest that the infusion of 0.5 mM DCA does not
produce edema at 1 hour and 1 day, and is therefore inappropriate for studies of
vasogenic edema. However, replication of this experiment may permit water content
increase to attain significance if additional trials produce similar T1 values on MRI to
those already documented in this study, and suggest the presence of vasogenic edema due
solely to infusate fluid at 1 hour post-infusion.
1.0 mM DCA
Consistent with the findings of Greenwood et al. (1991) and Seiffert et al. (2004),
we observed EB staining in the ipsilateral corpus callosum at 1 hour post-infusion of 1.0
mM DCA. In addition, MRI revealed T2 hyperintensity and significant increase in water
content consistent with the results of Seiffert et al. (2004). We therefore determined that
this infusion parameter induced edema by disruption of the BBB and extravasation of
serum albumin, and the significant ADC increase suggested a predominance of vasogenic
edema. As mentioned above, the infusate fluid likely contributes to the total edema,
which would suggest that the total edema volume in this parameter is a combination of
infusate fluid and extravasated serum fluid.
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At 1 hour, no GFAP upregulation was observed, but we did see swelling of
perivascular astrocytic end feet at the ultrastructural level. However, no glial somata
swelling was observed. The lack of GFAP upregulation suggests that the end foot
swelling did not contribute significantly to the observed edema. Further, perivascular
spaces and ECS expansion were apparent, and no other ultrastructural evidence of
cellular swelling was observed. These GFAP and ultrastructural findings are consistent
with the significant ADC increase, and the results as a whole suggest the existence of
pure vasogenic edema for this parameter. Our finding is consistent with the findings of
Greenwood et al. (1991), who endorsed 1.0 mM DCA as an optimal concentration for
BBB disruption that permits albumin extravasation without necrotic tissue damage.
Our findings show that this edematous state is dynamic in a time-dependent
manner. 1 day post-infusion of 1.0 mM DCA we observed no functional BBB disruption,
and no significant difference in both water content and ADC between ipsilateral and
contralateral, although both averages were greater than contralateral.

Some tissue

samples showed evidence of ECS expansion but could be attributed to artifact of tissue
process, as no perivascular spaces were observed. We therefore concluded that the DCAinduced BBB disruption is temporary, and that the brain had cleared the edema fluid seen
at 1 hour post-infusion, making the 1-day time point inappropriate for study of vasogenic
edema.
Ultrastructurally, no abnormalities were observed in myelin, axons, or glial
somata, suggesting that the edema produced by this treatment did not produce permanent
tissue pathology. However, GFAP upregulation and swollen perivascular astrocytic end
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feet were observed, indicating cellular swelling. Astrocytic function of extravasated
proteins may be the cause of this observed astrocyte reaction. Because MRI in no way
indicated cellular swelling and other ultrastructural characteristics were normal, the
observed astrocytic reaction is likely due to a small amount of protein clearance still
persisting at this time, which is consistent with previous findings that several days are
required for removal of albumin from the ECS (Ohata et al. 1990; Fatouros et al. 1990). .
These other studies have shown that clearance of proteinaceous fluid from the
brain takes 8 days (Ohata et al. 1990; Fatouros et al. 1990). The major clearance pathway
is currently thought to be through perivascular spaces (Ohata et al. 1990), but astrocytes
were previously thought to clear the majority of fluid (Klatzo 1987). The combination of
multiple mechanisms in edema clearance is well-supported nonetheless (Klatzo 1987)
(Ohata et al. 1990). At 1 day post-infusion of 1.0 mM DCA, our results showed neither
significant edema nor perivascular spaces, suggesting that a large amount of fluid had
cleared through the perivascular spaces as observed by Ohata et al. (1990). Swollen
astrocytes indicated that the astrocytic mechanism of clearance was also apparent,
although these did not show prominence until 1 day. Seiffert et al. (2004) also observed
GFAP increase following their 1.0 mM DCA perfusion over the cortex. In a later study
by this same group, they showed that astrocytes take up extravasated serum albumin
through the TGF-β receptor within 6-8 hours following 2.0 mM DCA perfusion over the
cortex (Ivens et al. 2007), and interstitial water would presumably follow the albumin
(Klatzo 1987).

This time course of albumin uptake by astrocytes explains why

significant astrocytic swelling was not observed at 1 hour. Due to our observations in the
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scope of work, we suggest that the fluid clearance following 1.0 mM DCA is attributable
to perivascular pathways and to astrocytic uptake, with the former predominating and
removing the majority of edematous fluid before the latter.
2.0 mM DCA, 1 Hour Post-infusion
Infusion of 2.0 mM DCA produced an ipsilateral necrotic lesion in the corpus
callosum proximal to the needle tip, which was surrounded by a region of mixed
vasogenic and cytotoxic edema, with a predominance of the former.

All MRI

measurements (T2 signal, water content, and ADC) suggested a predominance of
vasogenic edema throughout the region of interest at both time points.

However,

astrocytic swelling was observed ultrastructurally, suggesting that the edema was not
purely vasogenic.

Observed astrocyte morphology was consistent with documented

morphology of reactive astrocytes (Gomide et al. 2005), particularly through our
observation of interconnecting astrocytic processes. Interestingly we did not observe
ultrastructural abnormalities in glial somata at both time points, but these somata were
sparse relative to axons and blood vessels and perhaps further investigation could show
evidence of pathology.
Tissue necrosis due to 2.0 mM DCA is consistent with findings of the
aforementioned Greenwood et al. (1999) paper, in which the authors showed cell
membrane lysis and pathological cerebral blood vasculature following intracarotid
perfusion of DCA at concentrations of 1.5 mM and higher in exsanguinated rats.
Additionally, Ivens et al. (2007) showed BBB disruption by EB extravasation with 2.0
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mM DCA perfusion over the rat cortex, which we similarly observed with
intraparenchymal infusion.
These findings are consistent with our previous results showing BBB disruption
and vasogenic edema formation following a DCA infusion with a lower concentration
(1.0 mM). Together, they suggest a dose-dependence of DCA on BBB disruption, edema
formation and cytotoxicity following direct intraparenchymal delivery. In addition, we
suggest that infusion of 2.0 mM DCA does not produce pure vasogenic edema and is
therefore not optimal for study of this brain state.

Tumor-Bearing Rats
The qualitatively-assessed characteristics of the T9 glioma-bearing rats was
consistent with known features of peritumoral edema in the corpus callosum.
Peritumoral edema typically resides in the white matter (Raslan and Bhardwaj 2007),
which is where we observed our findings.

Mass effect, ipsilateral T2-weighted

hyperintensity, and ipsilateral GFAP upregulation in combination with ultrastructural
observations (e.g. perivascular spaces and expanded ECS ipsilaterally) suggested the
presence of ipsilateral edema, predominantly of the vasogenic type. To further support
this claim, no evidence of necrosis was observed in throughout the tissue.
The upregulated GFAP suggests astrocytic reaction to the proteinaceous fluid
extravasation. As mentioned before, however, astrocytic reaction to proteinaceous fluid
extravasation specifically involves uptake of the extravasated albumin without the fluid
in an effort to lower extracellular oncotic pressure (Stummer 2007).

Together, our

observed results in combination with the documented astrocytic response to peritumoral
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edema suggest a purely vasogenic edema state in the ipsilateral corpus callosum due to
the brain tumor. Still, measurement of water content would have quantitatively given
evidence for significant edema, and ADC measurement would have similarly provided
quantitative evidence suggesting a predominance of vasogenic edema.
Further, the effect on the ipsilateral corpus callosum observed at 1 hour following
1.0 mM DCA infusion parallel this peritumoral vasogenic edema state, with the exception
that GFAP was not upregulated significantly following DCA infusion at this time.
However, GFAP increased at the 1 day time point from this same treatment.

As

suggested above, the astrocytic response to extravasated albumin following this treatment
takes longer than 1 hour but less than 24 hours to occur. In the tumor, several days of
gadolinium enhancement around the tumor margin demonstrate that the BBB was
compromised for this time and presumably serum albumin would have extravasated.
This would have permitted enough time for the astrocytic response (upregulated GFAP)
to occur in the tumor, which is consistent the time-dependent GFAP increase observed
following 1.0 mM DCA infusion. It is important to remember that the observed BBB
disruption following a single DCA infusion was transient, whereas tumors continuously
maintain a disrupted BBB (Groothuis 2000). This is consistent with our observation of
no edema at 1 day post-infusion of 1.0 mM DCA, despite the observed edema at 1 hour
post-infusion.

Conclusion
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The purpose of these studies was to develop a model of pure vasogenic edema.
Preliminary experiments with several parameters of VEGF infusion did not indicate that
this technique would produce the desired result.

Alternatively, DCA infusion

experiments displayed a dose-dependence and time-dependence on the formation of
edema. Taken as a whole, we observed that infusion into the corpus callosum of 9 µL of
1.0 mM DCA over 45 minutes produces pure vasogenic edema 1 hour post-infusion.
Further, we suggest that the tumor-bearing rats exhibited peritumoral edema that was
purely vasogenic. Therefore, we suggest that this specific infusion parameter provides an
optimal model for the study of vasogenic edema, particularly as it pertains to the
vasogenic edema in the white matter surrounding brain tumors.
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